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Abstract
There is a need for innovation in medical implant devices through novel biomaterials that will
improve the quality of life. The first step in the creation of a foundation of knowledge and
technology to improve these implant devices is through the creation of new alloys with the
capabilities of biodegradation and bioabsorption without a toxic effect that will pass through
FDA regulatory procedures. In this study, unique heat treatment processing techniques coupled
with innovation in elemental alloying produced distinctive magnesium (Mg) based alloy systems.
The MgZnCa system was used as the underpinning system where four groups of novel alloys
were developed, which include the as-cast Mg−xZn−0.3Ca system, the heat treated
Mg−4.0Zn−0.3Ca system and as-cast and heat treated Mg−1.0Zn−0.3Ca system alloyed with
1.3% rare earth elements. All alloy groups were assessed through immersion corrosion tests
utilizing 0.9% NaCl physiological solution and MEMα cell culture medium, tensile and
compressive mechanical testing, and cytotoxicity assays. The increase of Zn content in the
Mg−xZn−0.3Ca system had an effect on phase precipitation and grain size refinement, which
caused an increase in mechanical strength and a reduction of corrosion resistance up to a Zn
content of 4.0 wt.%. The cytotoxicity assays determined that the Mg−4.0Zn−0.3Ca system
showed negative cytocompatibility with the MC3T3-E1 cell line which can be reduced or
eliminated by diluting the interaction between the two. The addition of rare earth elements
caused significant grain size refinement, increased corrosion resistance, increased mechanical
strength compared to the MgZnCa system, and positive cytocompatibility. Through this research,
novel Mg-based alloys were developed with the potential of being employed as orthopaedic
biomaterials capable of supporting the mechanical and physical function of an injured tissue
throughout the entire healing process.
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CHAPTER 1
Introduction
1.1 Orthopaedic Implants and the Medical Device Industry
Orthopaedics is a medical specialty that pertains to the diagnosis and treatment of
disorders, conditions, and injuries of the musculoskeletal system. More specifically, orthopaedics
is a branch of medicine focused on the skeletal system and related muscles, joints, ligaments, and
tendons. It was reported that in 2012 the orthopaedic device market consisted of 9.4% of the
worldwide device market share which was 4th in the Top 15 device areas [1]. Musculoskeletal
ailments and injuries account for more than 130 million visits to orthopaedic specialists per year.
One in four Americans suffer from musculoskeletal impairment resulting in more than $180
billion in sales annually [2]. In short, the orthopaedic device market is a large market. This is
important because a larger market allows time for error and the development of valuable
products, as well as time to produce a repeatable and scalable business model.
Orthopaedic fixation devices, which include joint reconstruction materials and
biomaterials, are used in the reduction of fractures, bone manipulation, soft-tissue injuries, and
reconstructive surgery. Reduction can be noninvasive (external splints and traction) or can
involve surgery to implant and replace artificial joints. After fracture reduction, internal,
external, or intramedullary fixation devices may be used to provide mechanical stability and
maintain the alignment of bone fragments during the healing process. A fixation device must be
strong and secure enough to allow early mobilization of the trauma area. Screws are used
primarily to provide interfragmental compression or to attach plates, which can then provide
compression, prevent displacement, and support the fragments during healing. Pins and wires
can be used for fixation of small fragments or fractures in small bones [2, 3]. Figure 1 describes
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commercial orthopaedic implant devices. In Figure 1a, the inferior view after the complete
mandibular component has been inserted through soft tissue tunnels to the fossa regions. The
chin bone has been attached with screws to the prosthesis. Figure 1b shows the right TMJ before
closure. The condyle is seated in the posterior part of the fossa component [4]. Figure 1c
illustrates the AnchorageTM Cross Plating System which uses an inset diagonal, cross-joint screw
to develop true mechanical compression across the fusion site [5]. Lastly in Figure 1d, an
interference screws is affixing a cadaveric ACL graft in where the arrows point out the pieces of
cadaveric bone at both ends of the graft [6].
(a)

(c)

(b)

(d)

Figure 1. Examples of commercial orthopaedic implant devices.
The global orthopaedic sector is a dynamic component of the medical device industry.
Highly competitive and forecasted to have a single-digit growth rate, the orthopaedic device
market is primarily driven by artificial joints and orthobiologics which are estimated to be worth
$17.5 billion and $9.6 billion by 2016 respectively. Segment growth is also boosted by the
increase in knee implants and hip and knee replacements. By 2015 the world orthopaedic
prosthesis market is anticipated to reach $19.4 billion, with growth driven by rising degenerative
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joint diseases like osteoporosis and arthritis. The main cause is an aging global population and
the desire to keep up an active lifestyle [2].
Although financial demographics remain favorable, medical devices have evolved and
become more complex. Consequently, the federal device-approval regulatory system has become
more stringent and scrutinized. The United States congress requires that high risk medical
devices should be sanctioned through a more rigorous premarket approval (PMA) process, which
requires clinical testing. Moreover, the Safe Medical Devices Act of 1990 requires the FDA to
either use the PMA process for high risk devices or reclassify them in a lower-risk category [7].
As a result, the medical device industry continues to feel a profound impact from a slowdown in
procedure volumes coupled with uncertainties and delays at the FDA. In 2001, the U.S. House
Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled
“Medical Device Regulation: Impact on American Patients, Innovation, and Jobs.” In this
hearing, Congressman Cliff Stearns argued that FDA regulation of medical devices is too
arduous which stifles innovation and drives device manufacturer overseas [7].
Furthermore, there have been disagreements between FDA leadership and the medical
device industry and politicians from states where device companies are located concerning the
clearance process. The Institute of Medicine (IOM) released an FDA-commissioned report in
2011 on the 510(k) clearance process and it concluded that it was impossible for 510(k)
clearance to assure the safety and effectiveness of devices and therefore recommended that it be
eliminated. FDA leadership however does not intend to implement this key recommendation of
the report [7].
Generating innovative products in the medical device industry has a lot of challenges that
must be addressed. Proper physical and chemical characterization along with thorough biological
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assessment of new medical devices and materials is vital to the success of future product
commercialization.
1.2 Degradable Biomaterials
The first step in the creation of a foundation of knowledge and technology to improve
orthopaedic implant devices is through the creation of new alloys with the capabilities of
biodegradation and bioabsorption without a toxicity effect. The degradation properties of
biodegradable implants in physiological environments are the key component in the interest of
implementing these types of implants for medical purposes. Metals, ceramics, and polymers can
all be used as biomaterials for implants. Physical properties of metals such as high impact
strength, high wear resistance, high ductility, and the ability to absorb high strain energy make
them applicable for orthopaedic load-bearing applications and fixation devices [8]. The
implementation of metallic degradable biomaterials as an implant material is not a novel concept.
In 1878, physician Edward C. Huse used Mg wires as ligatures to stop bleeding vessels of three
human patients [8, 9].
Commonly used biomaterials include stainless steel, titanium, and cobalt-chromium
based alloys because of their corrosion resistance, and consequently they are inherently
permanent type of alloys. Biodegradability and biocompatibility are characteristics that gives an
advantage to implants with these capabilities because they would be able to be resorbed and
expelled safely out the body after the trauma site is healed, eliminating the need for iterative
surgeries. In an effort to make more biocompatible implants, the emphasis for contemporary
implants is not only on devices that are able to physically function in complex biological
systems, but that will be successfully accepted by the body [8]. Surgeon Erwin Payr was one of
the most influential pioneers of medicine whose versatile clinical applications and reports
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inspired the advancement in the field of biodegradable Mg implants to various surgical areas. He
first started experiments on Mg resorption in 1892 and by 1900 he proposed that tissue oxygen
and water content, carbon dioxide, dissolved salts in blood, and the chemical processes in cells
were mainly responsible for Mg corrosion in vivo [9].
Mg and Mg-based alloys have been investigated as implants for over 100 years. Implants
containing Mg and Mg-based alloys are limited in the amount of approved alloys for commercial
use. Due to Mg’s good biocompatibility and biodegradability, and the possibility for bone
generation engenders encouragement for biodegradable Mg implants for orthopaedic implant
applications.
1.3 Research Objectives
The aim for this study is to provide innovation in medical devices that improve the
quality of life through the development of novel Mg alloys with the capabilities of
biodegradation without rendering a cytotoxic effect. More specifically, to create an assortment of
uniquely composed and processed biodegradable Mg alloys that have the potential to meet
different orthopaedic device requirements. To accomplish this, all alloys are produced according
to the “Design and Assessment for New Alloy Development” research plan flow chart in Figure
2. This chart is designed as a standard for materials development to promote consistency when
fabricating and characterizing all new materials developed in this study. The design objectives
for the alloys presented in this dissertation are driven by the “Device Design” requirements and
criteria of current orthopaedic medical devices which are described in the gray section. The
research detailed in this dissertation falls under the “Materials Development” section of the flow
chart.
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Materials Development

Medical Device
Device Design
Structure, Functionality,
Property Requirements,
Testing Strategy

Design Objectives

Alloy Development
Alloy Processing

Manufacturing
Prototype Development
Quality Control Protocols

No

Alloy Design

Basic
Characterization

Application-Driven Characterization

Testing
Pre-testing Evaluation
Device Testing
Post-testing Evaluation

Mechanical

Corrosion

Toxicology

Functional

Yes
Yes
In vivo
Models

Alloy Property – Device
Design Match

No

Figure 2. Design and assessment for “New Alloy Development” flow chart.
1.4 Dissertation Layout
The work presented in this dissertation has been organized under five chapters. Chapter 1
is dedicated to the introduction and explanation of pertinent background information to give a
better perspective for the research work presented in the study. It encompasses the orthopaedic
implant and medical device industry in which this research is purposed for, biodegradable
materials and alloy development as well as specific research objectives for this study.
Chapter 2 incorporates a comprehensive look into specific scientific literature and
commercial patents relevant to the work presented in this dissertation.
In Chapter 3, the concepts, set-up, and specifications of the experimental methods and
material characterizations are discussed.
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Chapter 4 is devoted to the results and discussion of all experimental procedures used in
this research work. Furthermore, recommendations for alloys produced in this study for
orthopaedic applications and future research work based on experimental results and inherent
opportunities.
Lastly, Chapter 5 summarizes this dissertation and the potential impact of the research
presented.
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CHAPTER 2
Literature Review
The main focus of this chapter is to review pertinent background information and
academic literature relevant to this field of study. Key theories and nomenclature will also be
discussed. In this chapter, current academic studies involving the fabrication and characterization
of biodegradable biomaterials consisting of Mg, zinc (Zn), and/or calcium (Ca) elements for
biomedical applications are discussed. Additionally, relevant existing commercial patents are
examined. Through the exploration of several current academic studies and commercial patents,
the research work in this study will have a foundation of pertinent information to compare and
contrast the novelty and impact of the results of this investigation.
2.1 History of Magnesium
Even though the history of Mg started in 1755 with the discovery of elementary Mg
contained within magnesia by Scottish chemist Joseph Black, the British chemist Sir Humphrey
Davy is credited as discoverer because he isolated the metal in 1808 [9, 10]. Sir Davy
decomposed wet Mg sulfate through electrolysis using a voltaic cell and a mercury cathode [10].
In 1831, the French chemist Antoine Alexandre Brutus Bussy discovered a way to isolate Mg in
large quantities by fusing dehydrated Mg chloride with potassium at elevated temperatures. He
published his findings in the 'Mémoire sur le Radical métallique de la Magnésie' shortly after.
Subsequently, British scientist and former Sir Humphrey Davy assistant Michael Faraday
reduced dehydrated Mg chloride by electrolysis and obtained pure metallic Mg in 1833 [10].
Throughout history, Mg found steady interest only in Germany, which, in 1868, was the
only producer in the world. On April 9, 1885, Aluminium und Magnesiumfabrik Hemelingen
was founded and started producing aluminum (Al) and Mg in an electrolytic process [10]. After
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years of advancement in the Mg production process and federal safety regulations, by 1915,
Germany remained the sole producer of Mg. In 1924 Mg alloys (AZ: 2.5-3.0% AL, 3.0-4.0% Zn)
were used for the first time as pistons in automobiles [10]. The application of Mg was extended
to a number of airship parts which included girdle connectors, steering gear fittings, and anchor
cable sheaves. Furthermore, Mg castings were introduced into cars on a larger scale by German
automotive engineer Ferdinand Porsche. As the years progressed, Mg production and application
grew and developed in Germany to include a patent for continuous production of metallic Mg
through thermic reduction.
The production of Mg has seen fluctuations throughout the 1900s, from production peak
in World War II, to the production decreasing drastically afterwards [10, 11]. In Germany, Mg
production was prohibited and ultimately terminated due, in part, to material shortages and the
Berufsverbot which was an order of professional disqualification or disentitlement.
In the United States, the Korean War created a need to revive Mg production in 1951
[10]. Part of the electrolytic plant of the Titanium Metals Corporation of America was
reactivated in 1950 to produce Mg for titanium reduction. After the Korean War, a strategic
stockpile of Mg was produced in the amount of 195,000 short tons, but the U.S. government
eventually sold the entire supply by auction. As the years progressed, the production of Mg was
developed for a number of applications that resulted in failure, but there was a level of success
focused toward transportation applications because Mg is a strong light weight metal that has
less density than aluminum and steel.
2.2 History of Magnesium Implants
The major limitation of Mg in many engineering applications is its low corrosion
resistance [12]. However, this intriguing feature has made Mg a potential prospect for a new
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class of implant biomaterials for orthopaedic applications. The employment of Mg in medical
applications is not a new idea. In 1878, physician Edward C. Huse successfully stopped a
bleeding vessel using a Mg wire ligature [9, 13]. He observed that the corrosion of Mg was
slower in vivo and that the time period of complete degradation was dependent on the size of the
Mg wire [8, 9]. In 1900, after concluding that the Mg wires Edward Huse implemented in his
blood vessel procedures were too brittle to be suitable sutures, Austrian-German surgeon Erwin
Payr investigated the use of thin-walled tubular Mg cylinders as replacement connectors for the
anastomosis of arterial and venous blood vessels [14]. Using pigs and the femoral artery of dogs
for his test trials, Payr discovered that the connection of blood vessel ends became solid after 8
days, and severely thickened intima later at the anastomosis. The vessel thickness returned to
normal after he waited 8 more days before reinvestigating the anastomosis [9]. It was noted that
only the Mg tubes that were positioned intravascularly caused thrombotic blood clotting and no
thrombosis was observed in the Mg tubes positioned extravascularly.
In terms of musculoskeletal applications, in 1900, Payr introduced the idea of using Mg
plates and sheets in joint arthoplastics to regain or preserve joint motion [9]. At the 29th Congress
of the German Society for Surgery, Payr lectured on the subject of using Mg sheets and plates to
prevent the reunion of dissected bone tissues by a dense fibrous layer after full resorption of the
Mg metal [9, 15]. This inspired the investigation of using Mg to regain motion stiffness in joints
through animal and human trials. Furthermore, Payr proposed the use of Mg implants which
include fixator pins, nails, wires (cerclage), pegs, and cramps for musculoskeletal applications;
more specifically using a Mg peg as a stabilizer for bone fractures and pseudarthrosis [9, 15].
In 1906, Albin Lambotte fixed a Mg plate using six steel screws at the tibia for
stabilization of a fracture of the lower leg of a 17 year old child [16]. It was discovered that the
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patient had a painful inflammatory reaction to the plate due to the electrochemical difference
between the Mg plate and the steel screws. After further investigation and animal test trials,
Lambotte began treating human patients with Mg implants under careful observation. He treated
patients suffering from supracondylar fractures with Mg nails and observed that there was
normal healing without complications except the development of gas cavities which disappeared
after several weeks [17]. Lambotte also observed total Mg resorption at one year post surgery
and physiological bone healing without any hypertrophic bone formation [9]. From these
findings, Lambotte broaden his clinical investigation and ultimately discovered the Mg could
only be implanted without combining other metallic implants to prevent electrolytic corrosion.
Based on his good clinical results, Lambotte recommended the use of Mg implants in the
following clinical areas: bennet fracture, scafoid fractures, foot surgery, clavicular fractures,
carpus fractures, phalanx and metacarpal fractures, radius epiphyseal fractures, lower arm
diaphyseal fractures, supra- and condylar fractures in children, humerus head fractures, malleolus
fractures, oblique tibial fractures and pertrochantic fractures [9, 16].
There has also been other reports on the use of Mg in orthopaedic applications, which
were mainly based on in vivo animal experiments [9]. In 1913, Ernest William Hey Groves
published his work on using a Mg intramedullary peg for stabilizing fragments in a fracture of
rabbits [18]. He discovered that Mg produced inflammation cavities and disintegrated so rapidly
that he deemed it undesirable. In 1924, Arthur A. Zierold compared the reaction of Mg on bone
and determined that Mg has little action other than as a connective tissue stimulant, and theorized
that it may hinder as well as accelerate new bone production [9, 19]. After many experiments and
thorough investigation on Mg and its alloys as implantable biomaterials throughout history, Mg
has established itself as an intriguing element worth the scrutiny and scientific debate. The many
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inherent benefits of Mg as an implantable material as well as a century of historical research has
push Mg to the forefront of potentially revolutionizing the biomedical engineering landscape.
2.3 Alloy Design
2.3.1 Alloying. Alloying is crucial in modifying the corrosion resistance and mechanical
properties of Mg [12, 20-23]. Alloying is the most effective method to modify the
microstructures and properties of Mg-based alloys. For example, it was found that the addition of
Zn can increase the age-hardening response of Mg alloys which can significantly enhance the
mechanical properties and corrosion resistance [24, 25]. The ternary addition of Ca to the
Mg−Zn system is effective for the improvement of mechanical properties [24, 25]. Moreover, the
mixture of rare earth elements (REE) in combination with other metals such as silver, and a
small amount of zirconium (Zr) which imparts a fine grain microstructure, can enhance the
mechanical properties of Mg [12].
2.3.2 Material selection.
2.3.2.1 Magnesium. Mg is the fourth most abundant mineral in the body and is vital to
certain biological functions. Mg is needed for more than 300 biochemical reactions in the body
which include muscle contraction, bone metabolism, and cellular proliferation. It helps maintain
normal muscle and nerve function, stabilizes normal heart rhythm, and supports a healthy
immune system [26]. Nearly 50% of the total Mg element in the body is found in bone and the
other half is found within cells of body tissues and organs [27-30]. Around 1% of Mg is found in
blood, but the body works vigorously to keep Mg levels within the blood constant [26].
The most commonly used biomaterials for orthopaedic devices include stainless steel
(SS), titanium (Ti), and cobalt-chromium (Co-Cr) based alloys. The possible release of toxic
elements during corrosion or wear processes create a significant weakness to these alloys as
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implantable biomaterials [12]. Mg has a density, elastic modulus, and compressive yield strength
closer to that of natural bone than for SS, Ti, and Co-Cr alloys. These similarities in properties
(Table 1) lead to minimal or no stress shield phenomena in Mg bone implants that occur with SS
and Ti alloys [31]. Additionally, histological studies show that new bone formation is observed
in vivo around Mg alloy implants without inflammation reaction [32, 33].
Table 1
Summary of the physical and mechanical properties of various implant materials in comparison
to natural bone [12].

Properties

Natural
Bone

Mg

Ti

Co-Cr

Stainless
Steel

Artificial
HA

Density (g/cm3)

1.8-2.1

1.74-2.0

4.4-4.5

8.3-9.2

7.9-8.1

3.1

Elastic Modulus (GPa)

3.0-20

41-45

110-117

230

189-205

73-117

Compressive Yield
Strength (MPa)

130-180

65-100

758-1117

450-1000

170-310

600

Fracture Toughness
(MPa·m1/2)

3.0-6.0

15-40

55-115

N/A

50-200

0.7

In terms of limitations, the corrosion resistance of Mg presents a major complication in
using it as an implant biomaterial [34]. Poor corrosion resistance of Mg alloys results from the
high dissolution tendency of Mg and the presence of secondary phases acting as local cathodes
causing micro-galvanic corrosion [35]. Consequently, Mg usually has a fast corrosion rate in
electrolytic physiological environments [12, 31].
Most Mg alloys are produced through metal casting techniques. One of the inherent risks
of metallic casting is the introduction of impurities or contaminants throughout the melt.
Common impurities found in Mg alloys include iron, copper, and nickel. Iron, copper, and nickel
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are detrimental to the corrosion resistance of Mg because they have low solid solubility limits
and provide efficient and active cathodic sites. This can lead to severe galvanic corrosion.
Matsubara et al. [36] concluded that the corrosion rate of AM50 and AM60 Mg alloys depended
on the impurity concentration of iron and increased with the iron-manganese ratio. Additionally,
impurities will also influence the microstructure and mechanical properties of Mg alloys. In
ZK60 Mg alloys, lower impurity content exhibited finer grains and subsequently an increase of
the yield strength in the as-extruded alloy was observed [37]. It is clear impurity content must be
considered in terms of producing successful Mg alloys for commercial use.
2.3.2.2 Calcium. Ca is the most abundant mineral in the body and the fifth most abundant
element by mass in the Earth’s crust. Ca is a silvery white alkaline soft metal and is essential to
all living things [38]. The average human contains about one kg of Ca, and Ca phosphate is the
main component of human bone. In terms of biological function, Ca is required for vascular
contraction and vasodilation, muscle function, nerve transmission, intracellular signaling and
hormonal secretion; though less than 1% of total body Ca is needed to support these critical
metabolic functions [39]. The remaining 99% of the body’s Ca supply is stored within the bones
and teeth to support their structure and function. Bone undergoes continuous remodeling with
constant resorption and deposition of Ca into new bone.
According to the Mg−Ca binary phase diagram, at 516°C, the maximum solubility of Ca
in Mg is 1.34 wt%. Li et al. [40] designed experimental alloys with a Ca content ranging from 120 wt%. It was discovered that the as-cast Mg−5, 10, and 20Ca alloys were very brittle at room
temperature and could be easily broken. Consequently, the Mg−Ca alloys had to be designed
with low Ca contents (1-3 wt.%). Li et al. ascertained from XRD patterns that the formation of
the secondary phase could be identified as Mg2Ca. The EDS analysis indicated that the grain
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boundaries were rich in Ca suggesting that the Mg2Ca phase precipitated along the grain
boundaries. However, inadequate mechanical properties as well as lower corrosion resistance
were two major limitations of the Mg−Ca binary alloy.
Bettles et al. [41] reported that the addition of trace amounts of Ca to a Mg−Zn system
led to a significant enhancement of age-hardening response by the refinement of the resulting
precipitate microstructure. In conjunction with the enhancement of the age-hardening response
by the addition of Ca, the optimization of the heat treatment cycle will result in further
improvements to the material properties.
2.3.2.3 Zinc. Zn is a metallic chemical element and is, in some respects, chemically
similar to Mg in terms of its ion size and its only common oxidation state of +2. Zn is the 24th
most abundant element in the Earth’s crust and is an essential mineral required by the body for
keeping a healthy immune system, building proteins, triggering enzymes and creating DNA [42].
Metallic Zn appeared much later in history than the other common metals [43]. Copper,
lead, tin, and iron can be obtained by a process called reduction, where their oxide ores are
heated with carbon to produce these elements as molten metals. Zn oxide, however, cannot be
reduced by carbon until temperatures exceed over its boiling point of 907°C and thus furnaces
developed to smelt the other metals could not produce Zn.
There are substantial benefits to utilizing Zn as an alloying element in Mg-based alloys. It
has been shown that Zn can significantly enhance the tensile strength, elongation and corrosion
resistance of Mg alloys. Du et al. [25] concluded that the addition of Zn is helpful to refine the
grain size of the as-cast Mg-3 wt.%Ca alloy. The grain boundaries become thinner and the grain
size is refined. Grain refinement is important in alloy development because it can improve
mechanical property and reduce corrosion rate. It was determined that the Mg−3 wt.%Ca−2
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wt.%Zn alloy shows higher mechanical strength and ductility than Mg−3 wt.%Ca [25].
Additionally, the eutectic (Mg+Mg2Ca+Ca2Mg6Zn3) phase in the Mg−3 wt.%Ca−2 wt.%Zn alloy
was found to improve its anticorrosion properties through potential dynamic polarization [25].
The addition of the Zn element shifts the corrosion potential towards the noble direction. Du et
al. [25] also found that the ultimate tensile strength of Mg−3Ca alloys is increased significantly
by adding the Zn element.
Sun et al. [44] prepared an Mg−4.0Zn−0.2Ca alloy for their investigation. XRD scans
were used to examine the phase of the as-cast alloy from 20 to 90° with a step size of 0.05
(Figure 3). Peaks from α-Mg, Ca2Mg6Zn3, and Ca2Mg5Zn13 were discerned in the as-cast alloy.
Additionally, the average grain size of the primary α-Mg phase was calculated to be 100-130 µm
(Table 2) and the spherical secondary phases had an average diameter of 1-2 µm which were
distributed mainly within the grains.

Figure 3. X-ray diffraction patterns of Mg−4.0Zn−0.2Ca alloys; (a) as-cast, (b) extruded [44].
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Langelier et al. [45] found that the addition of Zn to the Mg−Ca alloy system resulted in
significant improvement in the hardening capabilities through altering the precipitation process
and refining the precipitate distribution. This improvement in precipitation hardening can be
maximized by adding Zn in levels lower than its solid solubility limit.
Ohishi et al. [46] explored the optimum Zn composition for age-hardening in the
Mg−Zn−Ca ternary system. Table 3 list the compositions of the investigated alloys in both at.%
and wt.%. The Ca content of all alloy samples were fixed at 0.3 at.% (0.5 wt.%). The Mg−0.3Ca
binary alloy is used as a control alloy to compare the Mg−xZn−Ca ternary experimental alloys.
Table 2
Grain size and mechanical properties of Mg−4.0Zn−0.2Ca alloys [44].
Alloys

Grain Size
(µm)

Yield strength
(MPa)

Ultimate tensile
strength (MPa)

Ductility
(%)

As-cast

100−130

60±1.5

185±15

12.5±1.5

Extruded

3−7

240±5

297±5

21.3±3.0

After immersion

3−7

160±10

220±15

8.3±1.5

Ohishi et al. [46] concluded that the higher addition of Zn leads to completely different
precipitation reaction having three types of precipitates; rod-shaped -MgZn2 phase along the caxis of the Mg, fine plate-like Ca2Mg6Zn3 phase on the basal planes with coherent strain contrast,
and elongated basal plates along the 1 1 2 0 and 1 0 1 0 directions (Figure 4).
2.3.2.4 Rare Earth. The International Union of Pure and Applied Chemistry defines rare
earth elements (REE) or rare earth metals (REM) as a collection of 17 chemical elements in the
periodic table, specifically 15 elements in the lanthanide series along with yttrium (Y) and
scandium (Sc) which is described in Figure 5.
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Table 3
All compositions [46].
Designations

at.%

wt.%

Mg

Ca

Zn

Mg

Ca

Zn

Mg−0.3Ca

Bal.

0.3

−

Bal.

0.5

−

0.1Zn

Bal.

0.3

0.1

Bal.

0.5

0.3

0.3Zn

Bal.

0.3

0.3

Bal.

0.5

0.8

0.6Zn

Bal.

0.3

0.6

Bal.

0.5

1.6

1.0Zn

Bal.

0.3

1.0

Bal.

0.5

2.6

1.6Zn

Bal.

0.3

1.6

Bal.

0.5

4.2

Sc and Y are considered REEs because they tend to occur in the same ore deposits as the
lanthanides elements and exhibit similar chemical properties [47]. They are referred to as ‘rare’
because it is not common to find them in commercially viable concentrations. REEs generally
fall into one of two categories: light rare earth elements (LREE) and heavy rare earth elements
(HREE). The definition of LREE and HREE are based on the electronic configuration of each
rare earth element. The LREE are defined as lanthanum (La), with an atomic number of 57,
through gadolinium (Gd), with an atomic number of 64. The HREE are defined as terbium (Tb),
with an atomic number of 65, through lutetium (Lu) with an atomic number of 71, plus Y and Sc
with atomic numbers of 39 and 21 respectively. All of the HREE are different from the LREE in
that they have paired electrons. The LREE have no paired electrons, more specifically,
increasing unpaired electrons from 0 to 7 [47, 48]. Additionally, there are two groups: rare
elements with (a) high solid solubilities (Y, Gd, Tb, Dy, Ho, Er, Tm, Yb and Lu) and (b) limited
solubility (Nd, La, Ce, Pr, Sm and Eu) [49].
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Figure 4. A schematic illustrating four different types of precipitates [46].

Figure 5. Rare earth elements (metals) are often subdivided into light rare earth elements
(LREE) and heavy rare earth elements (HREE) [47].
Hort et al. [50] used Mg−2 wt.%Gd, Mg−5 wt.%Gd, Mg−10 wt.%Gd, and Mg−15
wt.%Gd alloys in their investigation. According to the Mg−Gd phase diagram (Figure 6), during
solidification the concentration of Gd in the solid is in accordance with the concentration as the
solidus line at a given temperature, and is in equilibrium with the concentration in the melt at the
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liquidus line. The material solidifies completely at the eutectic temperature of 548°C. The
solidified material cools slowly allowing the precipitation of Mg5Gd which dictates that an
amount of Mg5Gd should exist in all experimental alloys. However, XRD measurements could
not prove the presence of pure Gd, Mg5Gd, or oxides in the Mg−2Gd, Mg−5Gd, and Mg−10Gd
alloys, but the Mg5Gd phase could be confirmed in the Mg−15Gd samples. In the as-cast Mg−Gd
alloys, the grain size decreases with increasing Gd content illustrated in Figure 7. This effect is
common in terms of the alloying element Gd contributing to grain refinement to some extent.
The grains in all alloys, under all conditions are course. Hort et al. explains that the reason
behind this phenomenon is a relatively slow cooling rate during casting due to the high melt
temperature and mold temperature, and a 30 mm in thickness cast plate.

Figure 6. Mg−Gd phase diagram [50].
Most of the successful reports on in vivo application of Mg implants have investigated
Mg alloys that contain REEs [49]. REEs in Mg alloying are predominantly used for
strengthening and to improve corrosion resistance [51]. Some impurity elements in Mg, such as
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iron, severely deteriorates its corrosion resistance, and REEs can cancel their influence by the
formation of intermetallic compounds with the impurities [52]. Additionally, the corrosion
resistance of Mg mainly contingent upon the surface oxide film, the incorporation of REEs in
Mg(OH)2 lattice is responsible for the improved corrosion behavior of Mg alloy.

Figure 7. Grain sizes of the Mg−Gd alloys in the different heat-treated conditions [50].
2.4 Alloy Processing
2.4.1 Filtration. The filtration of molten metals through foam filters is a proven method
in order to remove or reduce harmful inclusions which can decrease the melt fluidity and
increase the possibility of gas porosity formation [53-55]. These defects that are produced by
harmful inclusions reduce mechanical properties, corrosion resistance, and machinability of the
metallic material [56]. During the filtration process, three stages occur. The first stage is the
initial stage which is usually short compared to the next two stages. In this initial stage, the melt
enters into some or all of the filter pores and consequently heats the filter if it is not already
preheated [57]. The next stage is the normal filtration stage where the flow of molten metal

24
through the filter is found to be constant. The last stage is the filter blockage stage in which the
molten metal flow decreases to near zero due to the formation of inclusions at the filter inlet and
the cooling of the melt [57].
There are several types of filters presently in the market which include strainer cores,
woven cloth or mesh, and ceramic filters. Pressed cellular, extruded cellular, and foam filters are
categorized as ceramic filters. Metallic filtration of a nickel based super alloy using a Al2O3based foam ceramic filter was found to be an effective means of controlling the level and particle
size of inclusions [58]. This type of filter was able to separate coarse particles from the melt,
intercept inclusions based on particle size, and entrap small blocky particles on the interior
surface of the filter.
There have also been studies done on the use of metallic filtration of molten metal.
Nazari et al. [57] used Al foam filters with 200 ppi pore size to filter molten Mg−Al−Zn alloy to
study the effects on the mechanical properties compared to the non-filtered alloy. It was
discovered that the utilization of Al filters resulted in a homogenized molten metal with smaller
and less porosity. As a result the bending strength values of the samples with filtered Mg were
higher than that of the samples that were not filtered. Wang et al. [59] utilized SS nets to
determine the effects on the mechanical and corrosion property for Mg−Gd−Y−Zr alloys. The SS
filtration was shown to not only remove the inclusions but also to better distribute finer
inclusions within the alloy. The mechanical properties greatly improved and the corrosion rate
decreased by the filtration treatment.
2.4.2 Heat treatment. Heat treatment is a metalworking process which includes a
combination of heating and cooling operations applied to a metal or alloy in the solid state to
obtain desired alloy properties [60]. For example, Zhou et al. [61] discovered that heat treatment
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significantly changed the corrosion resistance of an AZ91D alloy in simulated body fluid.
Compared to the as-cast condition, there was a reduction of the corrosion rate by 30-60%.
Furthermore, the mechanical properties of Mg containing Al-silicon alloys can be enhance by
heat treatment [21].
There are several techniques included under heat treatment processing. Solution heat
treatment is a process that alters the microstructure within an alloy through dissolving all solute
atoms to form a single-phase solid solution. This occurs as either a substitutional solution, where
the new atoms occupy sites in the host crystal lattice, or as an interstitial solution, where the new
atoms squeeze into “holes” between the atoms of the base lattice [62]. The amount of
strengthening depends on the amount of dissolved solute and the size difference of the atoms
involved. Since distortion of the host structure makes dislocation movement more difficult, the
greater the size difference, the more effective the addition [62].
The solution heat treatment process is a technique in which an alloy is heated to a suitable
temperature and held at this temperature for a sufficient length of time to allow a desired alloying
element to enter into the solid solution. This is followed by rapid quenching or cooling in a
suitable liquid to obtain certain material properties. Quenching prevents components that
normally form the secondary phase through low temperature processing from occurring by
trapping the secondary phase within the parent lattice which produces a supersaturated solid
solution single phase [60, 62].
T4 heat treatment is the combination of solution heat treatment and natural aging. Aging
describes a time-temperature dependent change in the properties of an alloy. As a result of aging,
there is a precipitation from the solid solution of one or more alloying elements whose solubility
decreases with decreasing temperature [60]. This technique works by adding atoms of one
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element (alloying element) to the crystalline lattice of the base metal. The alloying element
diffuses into the matrix forming a solid solution [63, 64]. T4 heat treatment is reasonably cheap
and easy to perform and provides a microstructural modification resulting in improvements of
mechanical properties [20, 23]. Liu et al. [65] found that T4 heat treatment has the ability to
increase corrosion resistance in the Mg−3 wt.%Zn alloy.
Ohishi et al. [46] conducted additional heat treatment processing of the Mg−xZn−0.3Ca
alloys by solution treatment at 500°C for 2 h and then quench into water. Aging was done in an
oil bath at 200°C. In terms of the age-hardening response of the Mg−xZn−0.3Ca alloys
investigated by Ohishi et al., the Mg−0.3Ca binary sample exhibits little age-hardening where its
hardness peak is 50 HV at ~30 h according to the 500g Vickers hardness test (Figure 8). Ohishi
discovered that the peak hardness of the Mg−0.3Ca alloy can be increased with the addition of
Zn, and the peak aging time becomes shorter. The peak hardness of the Mg−0.3Zn−0.3Ca and
Mg−0.6Zn−0.3Ca samples are 66 and 69 HV which is achieved in ~2 h, respectively. As the Zn
content increases beyond 0.6 at.%, the age-hardening response lowers. The peak hardness of the
Mg−1.6Zn−0.3Ca sample is 62 HV at ~70 h, which is still higher than that of the binary alloy. It
was concluded that the Mg−0.6Zn−0.3Ca alloy shows the best age-hardening response in the
alloys investigated in this work. The ordered monolayer Guiner-Preston (G.P.) zones were
formed during aging until the peak-aged condition suggesting an excellent thermal stability. The
G.P. zone is the first stage of precipitation as the precipitates comes out of the solid solution and
is usually accompanied by a change in properties of the solid solution. Ohishi observed that the
G.P. zones were detected in the Mg−0.3Zn−0.3Ca and Mg−0.6Zn−0.3Ca alloys, but not in the
Mg−1.6Zn−0.3Ca alloy. Ohishi ultimately concluded that the monolayer ordered G.P. zones
contributed to the enhanced age-hardening response.
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Figure 8. Age-hardening curves of Mg−0.3Ca with different Zn contents at 200°C [46].
Hort et al. [50] applied T4 treatment to the Mg−Gd alloys developed in their study. For
the T4 treatment, a temperature of 525°C was chosen and the samples were annealed for 24 h.
Specimens were water quenched immediately after heat treatment. T6 treatment was also
conducted which include aging at 250°C for 6 h. The eutectic phase Mg5Gd can be observed at
the grain boundaries in all the as-cast samples. After T4 treatments most of these particles
dissolve, though some still remain. The subsequent T6 treatment leads to the precipitation of
very fine particles in all alloys except for the Mg−2.0 wt.%Gd sample. Selected area diffractions
indicate that these fine precipitates are the metastable phases , which is homogeneously
distributed over the matrix, and , which can be observed in limited areas, after aging.
2.5 Mechanical Property Assessment
Assessing the mechanical properties of biomaterials is crucial in the development of
orthopaedic biomaterials. Biomaterials designed for orthopaedic medical devices must be able to
provide maintain the mechanical integrity of an injured site throughout the entire healing
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process. Several studies on the mechanical capabilities of Mg alloys have been done. The
mechanical properties of the as-cast Mg−xCa system conducted by Li et al. [40] revealed that the
yield strength, ultimate tensile strength and the elongation for the as-cast Mg−xCa samples
decreased with increasing Ca content (Figure 9). It can be seen that the as-cast Mg−xCa samples
have yield strengths and ultimate tensile strengths that are lower than the acceptable values
(200−400 MPa) for biomedical applications [40]. Therefore there is a need for further alloying or
processing techniques to modify the as-cast Mg−xCa alloy to obtain the appropriate mechanical
integrity.
Sun et al. [44] carried out tensile tests on the Mg−4.0Zn−0.2Ca alloy at a constant
crosshead speed of 1.0 mm/min at room temperature. Table 2 summaries the grain size and
mechanical properties of the Mg−4.0Zn−0.2Ca alloy produced this study. The alloying effect of
Zn and Ca contributes to the modification of mechanical properties.

Figure 9. Tensile properties of as-cast Mg−Ca alloy samples at room temperature [40].

29
Zn was found to have a solution hardening effect on Mg and therefore the precipitation of
Ca2Mg6Zn3, and Ca2Mg5Zn13 could enhance the strength and toughness of the alloy. The as-cast
the Mg−4.0Zn−0.2Ca alloy mainly consists of α-Mg and particle phases. Sun explains that the
stacking fault energy of Mg alloys decreased with high content of solid solution Zn.
Consequently, the extended dislocations were broadened which resulted in higher difficulty in
the initiation of non-basal slip. As a result, twin nucleation, which can be promoted by the
precipitation of particles, becomes an important plastic deformation mode. Therefore, the as-cast
Mg−4.0Zn−0.2Ca alloys had high ductility.
In terms of the effects of the REE on Mg, tension and compression studies, conducted by
Hort et al. [50], were performed on the Mg−Gd alloy. From Figure 57 (Appendix), it can be seen
that increasing the amount of Gd in Mg improves the ultimate tensile strength (UTS) as well as
the tensile yield strength (TYS), while the elongation to fracture (El) is reduced. Hort concluded
that the increase in TYS and UTS with increasing amounts of Gd is mainly attributed to the
increase in Gd in solid solution in the α-matrix.
With respects to the heat treatment effects on the tensile properties, the solutionizing
temperature (525°C) and time (24 h) allowed the precipitates of Mg5Gd to dissolve during the T4
treatments. For the alloys with a Gd content of 10 wt.% or less, grain growth could be observed,
and consequently both the dissolution of precipitates and the grain growth contributes to the loss
in strength after the T4 treatments. In terms of the compression strengths, an increase in Gd leads
to increases in the compressive yield strength (CYS) and the ultimate compressive strength
(UCS) and a decrease in the deformation in compression. These results follow a similar trend to
the results obtained in tension except that the absolute values are higher compared to the tensile
results. It is clear to see that the alloying and heat treating processes are a key component in
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developing Mg biomaterials that will be able to handle the mechanical requirements of an
orthopaedic implantable medical device.
2.6 Corrosion Assessment
The degradation behavior is important characteristic of orthopaedic biomaterials because
this can have an effect on the mechanical integrity and biocompatibility of the material.
Biodegradable materials are designed to provide temporary support during the healing process of
injured tissue and then degrade afterwards [66]. Thus, several studies have been conducted on
Mg alloys to develop a biomaterial with suitable corrosion resistance for medical implant
applications.
Li et al. [40] conducted an immersion degradation test on Mg−xCa (x = 1−3 wt.%)
samples in simulated body fluid (SBF) according to the ASTM-G31-72 standard. SEM
micrographs (Figure 10) show the corrosion surface of Mg−xCa samples immersed in SBF after
5 h.

Figure 10. SEM micrographs of as-cast Mg−Ca alloys after immersion in SBF for 5 h: (a) as-cast
Mg−1Ca alloy, (b) as-cast Mg−2Ca alloy, and (c) as-cast Mg−3Ca alloy [40].
As seen in Figure 10a, the Mg−1Ca sample maintained the integrity of the corrosion film.
For the Mg−2Ca sample, some areas exhibited the peeled-off surface feature whereas other areas
were still covered with integrated surface film. After a 250 h immersion time, the Mg−1Ca and
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Mg−2Ca samples were found to be covered entirely with white precipitates and the square
geometry of the samples were severely destroyed. For the Mg−3Ca sample, the plate degraded
too fast and disintegrated into fragments after 24 h exposure.
In terms of electrochemical corrosion testing, according to the ASTM-G102-89 standard,
the corrosion rates derived from the corrosion current densities for the as-cast Mg−1Ca, as-cast
Mg−2Ca, and as-cast Mg−3Ca samples were calculated to be 12.56, 12.98, and 25.00 mm/year,
respectively. A model of the alloy and aqueous solution interaction was created to describe the
corrosion processes and the subsequent hydroxyapatite formation (Figure 11). Li explained that
when the Mg−Ca alloy surface was exposed to the aqueous solution, the Mg2Ca secondary phase
acted as a cathode for hydrogen evolution because the potential of Mg2Ca precipitate was more
positive than that of the α-Mg matrix. The anodic dissolution of Mg occurred, and the Mg
hydroxide film was expected to form on the surface of Mg−Ca alloy due to the significant
alkalization near the surface. Since an increase in Mg2Ca amount would lead to an increase in
cathode-to-anode area, it could explain why the corrosion rate obtained from electrochemical
tests increased with increasing Ca content. Li suggests that to meet the requirement of the
harmonization between implant biodegradation and new bone formation, the addition of other
elements and heat treatment processing could retard biocorrosion and improve corrosion
resistance, respectively.
Sun et al. [44] conducted a 30-day immersion degradation test on the Mg−4.0Zn−0.2Ca
alloy in c-SBF. The Mg−4.0Zn−0.2Ca samples degraded quickly, accompanied by the release of
hydrogen and form of an insoluble corrosion layer during the early stage of the immersion test.
After the formation of the corrosion layer, the degraded rate began to slow down as a result of
the insoluble corrosion layer retarding the degradation.
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Figure 11. Schematic diagram of the alloy/solution biocorrosion interface: (a) the galvanic
corrosion between Mg and Mg2Ca phase, (b) the partially protective film covering the surface of
Mg−Ca alloys, (c) the absorption of chloride ions to transform Mg(OH)2 into MgCl2, (d) the
hydroxyapatite formation by consuming Ca2+ and PO
 , and (e) the disintegrated particle-shape
residues falling out of the bulk substrate [40].
The degradation rates, which were obtained according to the ASTM-G31-72 standard,
after 30-day immersion are listed in Table 4. The degradation rates of the Mg−4.0Zn−0.2Ca
samples were slower than the pure Mg (> 99.99%) control group. Sun explains that with the
increasing time of immersion, more Mg2+, Zn2+ and Ca2+ ions were dissolved into the SBF
solution. As a result, an Mg-containing Ca phosphate precipitated from the SBF solution and
deposited on the surface of the samples. Previous studies [67] conclude that this corrosion layer
has the ability to promote osteo-inductivity and osteo-conductivity, predicting good
biocompatibility and retarded degradation. Therefore the degradation of Mg−4.0Zn−0.2Ca in
Sun et al. study is concluded to be harmless and to have good biocompatibility.
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Table 4
Corrosion potential, corrosion current, and corrosi
corrosion rate of Mg and Mg−4.0Zn−0.2Ca
−4.0Zn−0.2Ca alloys
[44].
Materials

E (V)

Current (A/cm2)

V (mm/year)

Pure Mg

−1.906

3.715 × 10−4

2.13

As-cast Mg−4.0Zn−0.2Ca

−1.70

2.67 × 10−4

2.05

Extruded Mg−4.0Zn−0.2Ca

−1.677

2.43 × 10−4

1.98

Figure 12. Corrosion rates determined by hydrogen generation and weight loss measurements
[50].
The corrosion resistance of the Mg
Mg−RE alloys investigated by Hort et al. [50] was
conducted through immersion tests in aerated 1% sodium chloride (NaCl) solution. The
corrosion rates were determined by calculations based on the hydrogen formation and weight
loss shown in Figure 12. It can be seen that with increasing Gd up to 10 wt.% for the as-cast
as
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condition, the corrosion rate decreases. The Mg−15Gd values, which have a higher Gd amount,
lead to a drastic increase in the corrosion rate. Hort explains that compared to the other binary
alloys, the fraction of the grain boundaries is larger for the 15 wt.% Gd alloy. They also note that
the Ni content in the Mg−15Gd was the highest observed.
2.7 Cytocompatibility Assessment
Several studies have been conducted on the cytocompatibility of Mg alloys. In the
cytocompatibility studies presented by Li et al. [40], the Mg−1Ca alloy underwent cell viability
examination. Figure 13 describes the cell viability of L-929 cells cultured in 100%, 50%, and
10% Mg−1Ca alloy extraction medium for 2, 4, and 7 days.

Figure 13. L-929 cell viability expressed as a percentage of the viability of cells in the control
after 2, 4 and 7 days of culture in Mg−1Ca alloy extraction media with 100%, 50%, and 10%
concentrations, respectively [40].
There was a significantly higher absorbance in the Mg−1Ca alloy extracts than that of the
control. In addition, the cell viability was positively influenced by the extract concentration. Li

35
explains that the abundant Mg ions released into the culture medium by the corrosion of
Mg−1Ca
−1Ca alloy might contribute to the incr
increased
eased cell viability. Mg ions were found to simulate
the integrin-mediated
mediated osteoblast response by facilitating the interaction of integr
integrins
ins with their
cognate ligands [40].
Sun et al. adopted L-929
929 cells to evaluate the cyto
cytocompatibility of Mg−4.0Zn−0.2Ca
−4.0Zn−0.2Ca
alloys as well. Cells were incubated with Mg
Mg−4.0Zn−0.2Ca
−4.0Zn−0.2Ca extract for 1, 2, 4, and 7 days (Figure
(
14). Sun determined that the Mg−4.
−4.0Zn−0.2Ca
−0.2Ca alloy has a level of biosafety suitable for in
cellular applications according to the ISO 10993
10993-5: 1999 standard [68].

Figure 14.. Cell viability cultured in 100% extraction medium for 1, 2, 4, and 7 days [44].
2.8 Commercial Patents
Xiaonong Zhang received a patent entitled, Bio-absorbable Mg-Zn-Ca
Ca three-elements
three
magnesium alloy material in 2006 [69]. This invention deals with the development of an
absorbable Mg−Zn−Ca
−Zn−Ca ternary alloy system to be used for biomedical applica
applications.
tions. The alloy
system in this invention comprises of the following components by weight percentage: 1-8%
1
Zn,
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0.1-2% Ca, and a balance Mg. Zhang claims that for optimum mechanical property and
biological corrosion performance, the ideal weight percentage for Zn and Ca are 6±0.5% and
0.5±0.1% respectively. For this composition, Zhang claims that the tensile strength (300 MPa)
and ductility (8-10%) can guarantee excellent performance in medical applications. The
Mg−Zn−Ca alloy in this invention consists of high purity raw materials and high cleanliness of
smelting technology to manufacture. The purity of the raw material should not be less than
99.99% Mg, 99.999% Zn, and 99.75% Ca. Melting and casting procedures require the use of
high purity argon inert gas, the use of special graphite or titanium melting crucible, and a melting
temperature of about 750°C.
Additionally, the United States patent entitled Implant with a base body of a
biocorrodible magnesium alloy by Bodo Gerold presents an invention that has improved
corrosion behavior and mechanical properties for implants made of a biodegradable Mg alloy
[70]. The Mg alloy claimed in this patent has the composition of:
•

Gd: 2.7-15 wt.%

•

Zn: 0-0.5 wt.%

•

Zr: 0.2-1.0 wt.%

•

Nd: 0-4.5 wt.%

•

Y: 0-2.0 wt.%
Mg and the impurities due to the manufacturing process account for the remainder up to a

total of 100 wt.%. The alloy can be produced and processed according to the procedures for
manufacturing common Mg alloys. Gerold explains that the preferred amount of Gd is 7.0-13.0
wt.% to ensure the pharmacological effects of the Gd ions released on degradation of the
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material in the body. The preferred Zn concentration is 0.1-0.5 wt.% and the preferred addition
of Zr to improve the corrosion properties is 0.2-0.7 wt.%. The preferred Nd content of the alloy
is 2.0-2.5 wt.% which can improve the mechanical properties. If the Nd content exceeds 4.5
wt.%, then the ductility of the alloy is worsened because of the limited solubility of Nd. The
alloy in this invention is characterized in that complete or almost complete dissolution of all the
precipitated intermetallic phases is achieved by heat treatment. Consequently, the required
plastic deformability and desired mechanical properties of the material are preserved over the
entire manufacturing process. The inventive alloy exhibits improved strength. For example the
range between the onset of plastic deformation and reaching the tensile strength and/or
compressive strength is optimized according to the uniform elongation. The elongation range is
large and shows a uniform increase in the stress, strength and deformability required for further
deformation. For stents, the patent claims that the material allows an improvement in the
supporting force and the diameter of the struts in the stent can be kept small. Additionally, the
alloy is claimed to have a reduced corrosion tendency in a physiological environment. In terms
of in vivo degradation, the claim is that the alloy evidently also has a positive pharmacological
effect on the surrounding tissue, according to preliminary experiments, in particular in the case
of a stent used as intended. The preferred implant for the alloy claimed in this patent to be
implemented is a stent.
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CHAPTER 3
Experimental Methods and Concepts
In this chapter, the materials preparation, microstructure assessment, mechanical tests,
corrosion test, and cytocompatibility assessment used for the experiments are described and
discussed. The statistical analysis of all quantitative data produced by scientific experiments is
also explained in this chapter.
3.1 Materials Preparation
3.1.1 Design strategy. Design strategy is one of the more critical steps to the success of
creating a viable biomaterial. The two alloy systems selected to be studied for this research work
were the magnesium-zinc-calcium system and the magnesium-zinc-calcium-rare earth system
based on their intriguing alloying characteristics (Table 5) which was discussed in more detail in
Chapter 2.
Table 5
Elements alloyed with the based magnesium and reasoning behind the usage of these alloys in
this research project.
Name
MgZnCa

MgZnCa-RE

Elements
Zinc

Attractive Characteristics
Elevates corrosion potential and improves corrosion
resistance; improves hardening capabilities; refinement of
precipitates

Calcium

Major component in human bone and can accelerate bone
growth; grain refinement and creep resistance

Rare Earth

High strength and ductility; improve mechanical
properties; corrosion and creep resistance
Grain refinement; increase strength

Zirconium

3.1.1.1 Magnesium-zinc-calcium system. The effects of Zn content on the as-cast
Mg−Ca system was investigated in this study. The Zn concentrations started at 0.5 wt.% and
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were increased systematically to 10.0 wt.% and are designated as M-46 to M-53, respectively
(Table 6). All samples of the Mg−xZn−Ca system were produced with the Ca concentration of
0.3 wt.%. Ca has low solubility in magnesium which come to only 0.2 wt.% at room temperature
and 1.2 wt.% at high temperature in the equilibrium state and consequently is maintained at a
lower level [71].
3.1.1.2 Magnesium-zinc-calcium-rare earth system. All samples of the MgZnCa−RE
system were produced with 1.0 wt.% Zn, 0.3 wt.% Ca, and 1.3 wt.% rare earth alloys.
3.1.2 Alloy processing. The innovative aspect of this research was based on the alloy
processing which dictates the uniqueness of each alloy. The processing, characterization, and
screening of each alloy was done with the following fundamental questions in mind [72]:
1.

What are the most critical steps during Mg processing and/or Mg implant production to
imprint harmful impurities into the Mg material?

2.

What are the most important parameters that are mandatory to be included in a bench test
(materials screening test) to determine whether a biodegradable Mg material is suitable as a
biomaterial?

3.

What are the most relevant environmental factors to replicate in a bench method to ensure
that the intermediate and ultimate byproducts are consistent with those generated throughout
in vivo use?
3.1.2.1 Melting and casting. All alloys fabricated in this study were produced through

common metal casting techniques. Melting and alloying operations were performed in a low
carbon steel crucible in an inert UHP grade argon environment, which prevents the oxidation
reactions of molten Mg. High purity Mg (99.97%) was heated at 710°C for 10 minutes or until
the slug was completely melted.
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Table 6
Nominal composition of as-cast Mg−xZn−Ca system in weight percentage and the Mg
concentration is in balance.
Alloy Name
M-46
M-47
M-48
M-49
M-50
M-51
M-52
M-53

Elemental composition (wt.%)
Zn

Ca

0.50
1.00
2.00
3.00
4.00
5.00
6.00
10.00

0.30
0.30
0.30
0.30
0.30
0.30
0.30
0.30

Each alloying element was then added separately and kept for 10 minutes before adding an
additional alloy to ensure all alloying elements were completely dissolved into the melt.
Automated stirring was applied for 15 minutes to help provide a homogeneous distribution of
elements throughout the melt. The melt was then raised to 730°C (Mg−xZn−0.3Ca alloys) or
750°C (MgZnCa−RE alloys) for 15 minutes and then poured into a steel book mold.
3.1.2.2 Heat treatment. Levi et al. [73] discovered that at 465°C for the Mg-1.6 wt.% Ca3.2 wt.% Zn alloy, more than 2% of the microstructure at equilibrium is liquid. In order to
prevent or minimize the grain boundary melting, Levi followed a four-step heating procedure
which consisted of: (1) holding at 300°C for 48 h; (2) quasi-stationary heating (1°C/h) to the
holding temperature; (3) holding at 465°C for 96 h; followed by (4) water quenching.
Therefore, a double stage heat treatment process was implemented for this study in an
effort to prevent the melting of the grain boundary during the solution treatment process. To
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optimize this double stage solution treatment process for the Mg−xZn−0.3Ca alloys, several
different time and temperature parameters were explored for this study.
The first stage of the T4 solution heat treatment process was conducted at a low
temperature (300°C or 320°C) for a specific amount of time (20−48 hours). The second stage
includes additional solution treatment at a higher temperature (400−480°C) for a specific amount
of time (2−144 hours). Quenching was done in hydraulic oil. The temperature of the first stage
was chosen based on the structural studies on the Mg−4.0Zn−0.4Ca alloys conducted by
Hradilová et al. [74]. From the results of their differential scanning calorimetry (DSC), the DSC
curves indicated that there were two endothermal peaks at 340°C and 390°C for the as-cast alloy
which was determined to be the presence of the α-Mg+MgZn eutectic phase at 340°C and the
Ca2Mg6Zn3 phase at 390°C. For the T4 heat treated Mg−4Zn−0.4Ca alloy, the DSC curve
indicated that the 340°C peak found in the as-cast curve was suppressed by the T4 treatment.
However, the peak at 390°C which indicates the presence of the Ca2Mg6Zn3 phase remained
unchanged. As a result, the temperature of the first stage in the solution treatment process in this
study was held under 340°C. According to the binary phase diagram of Mg−Zn, the solidus line
is at about 510ºC. Therefore, at 480ºC, the alloy should not start to melt. Nevertheless, if the
alloy was directly heated to 480ºC at a quick ramp rate, the secondary phase preferably at the
grain boundaries would melt, which would lead to heat treatment defects. To avoid this
phenomenon, a slow ramp rate of 1°C/min was used to reach the treatment temperature in the
first stage and a ramp rate of 0.1°C/min was used for the second stage. This allowed part of the
secondary phase to dissolve into the Mg-matrix in solid phase.
The MgZnCa−RE alloys were also introduced to heat treatment processing. Hort et al.
determined that introducing T4 treatment at 525°C for 24 h to the Mg−Gd system was effective
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in dissolving eutectic particles into the primary matrix. Consequently, a double stage T4
treatment process was conducted in which the first stage consisted of a temperature of 400°C for
20 h and then an additional treatment of the second stage at 500°C for 2, 4, 6, and 8 h. The
double stage treatment was done with the same ramp rates as described above.
3.2 Microstructure Assessment
3.2.1 Polishing and etching. Careful and meticulous surface preparation must be made
to reveal the important details of a microstructure. The specimen must first be polished to a
smooth and mirror-like finish [64]. Polishing is often used to enhance the look of a component,
prevent contamination of instruments, remove oxidation, or prevent corrosion in pipes. For this
study, in order to observe the grain structure of the samples, a metal polishing technique was
applied. All samples were polished initially using a 600 grit silicon carbide polishing paper. Each
subsequent polishing stage used a finer grit paper which included 800, 1000, and 1200 grit
silicon carbide polishing paper. Additional polishing was performed using 3 µm, 1 µm and 0.05
µm diamond suspension solution until a mirror finish was achieved.

Figure 15. Schematic of a section view of grains showing how the etching characteristics and
resulting surface texture can vary from grain to grain [64].
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After polishing, etching was introduced to each sample. Chemical etching is the process
of revealing microstructural details that would not be evident on an as-polished sample. The
etchant corrodes the microstructural features making it more concise and clear to define. The
chemical reactivity of the grains of some single-phase materials depends on crystallographic
orientation. Consequently, in a polycrystalline specimen, etching characteristics vary from grain
to grain. Figure 15 illustrates how normally incident light is reflected by three etched surface
grains, each having a different orientation. The surface structure of an alloy as it might appear
when viewed with the microscope; the luster or texture of each grain depends on its reflectance
properties [64]. All samples were etched with a 5% nital solution. Additional etching was
performed with picric acid solution on certain samples to achieve better grain contrast.
3.2.2 Grain size evaluation. The Heyn Lineal Intercept procedure was used to estimate
the average grain sizes of all alloys [75]. After polishing and etching, images of the
microstructure of each sample were taken using the Zeiss Axio Imager 2 optical microscope.
Optical microscopy (OM) is a type of microscope that uses light and a system of lenses to
magnify images of samples. Fifteen identical in length test lines were used for each alloy. The
number of intercepts within each test line is counted at a 5x magnification. An intercept is a
segment of test line overlaying one grain. Since a 5x magnification was used, the intercept
numbers and the lineal length of each test line were converted based on a 1x magnification using
the equations below:


N  N  


Equation 1

Ni is the number of intercepts within a test line; Ni0 is the number of grains intercepted by the test
line at magnification Mb which is the basic magnification at 1x. M is the observed magnification.


L  L   

Equation 2
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L is the length of the test line and L0 is the test line at magnification Mb. When counting
intercepts, segments at the end and the beginning of a test line which infiltrate into a grain were
counted as half intercepts. The number of intercepts per unit length of each individual test line
(NL) was calculated using,
N 





Equation 3

The average NL for each sample was then calculated. The ASTM grain size number (G) was
subsequently determined using,
G  "3.2877 ' 6.6439 log N

Equation 4

The average grain diameter is then ascertained from the ASTM grain size number utilizing the
“Grain Size Relationships Computed for Uniform, Randomly Oriented, Equiaxed Grains”
information found in the ASTM standard E 112-10 [75].
3.2.3 Elemental mapping and spectroscopy. Elemental mapping at the microstructure
level by scanning electron microscopy (SEM) with energy dispersive X-ray spectrometry (EDS)
has been widely applied in science and engineering. Combining the EDS system with the SEM
allows the identification of compositional gradients at grain boundaries, second phases,
impurities, inclusions, and small amounts of material. In the scanning mode, the SEM-EDS can
be used to produce maps of element location, concentration, and distribution. Figure 16 depicts a
schematic of a typical scanning electron microscope. Generally, the quality and resolution of
SEM images are a function of three major parameters: instrument performance, selection of
imaging parameters, and the nature of the specimen [76]. The main components of a traditional
SEM are electron column, scanning system, detectors, display, vacuum system, and electronic
controls. The electron column of the SEM consists of an electron gun and two or more
electromagnetic lenses operating in vacuum.
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Figure 16. Schematic of a conventional scanning electron microscope [76].
The electron gun generates and accelerates free electrons to energies in the range of 0.2
keV to 40 keV, which are focused or condensed by the electron lenses to create a small stable
electron beam on the specimen [76, 77]. Most SEMs, with the help of the scanning coils, can
create an electron beam at the specimen surface with a size less than 10 nm in diameter while
still carrying a sufficient current to form an acceptable image. Each point on the specimen that is
struck by the accelerated electrons emits a radiated electromagnetic signal. Selected portions of
this radiation, usually secondary (SE) and/or backscattered electrons (BSE), are collected by a
detector and the resulting signal is amplified and displayed on the computer monitor [76]. The
interaction of an electron beam with the surface of a specimen and the size and characteristics of
that interaction volume is important for both the physical foundation for imaging and the
chemical or X-ray analysis of the sample. The interaction of an electron with a specimen
provides a wide variety of signals that can provide a signature of the specimen, specifically
information on its structure and chemical composition [78]. The schematic representation of the
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various signals generated as a result of electron beam interaction with a specimen is shown in
Figure 17.
The EDS system utilizes the X-ray spectrum emitted by a specimen that is bombarded
with the electron beam to obtain a localized chemical analysis. All elements from Beryllium
(atomic number 4) to Uranium (atomic number 92) can be detected in principle [79]. Qualitative
analysis involves the identification of the lines in the spectrum and is fairly straightforward
owing to the simplicity of X-ray spectra. Quantitative analysis or the determination of the
concentrations of the elements present entails measuring line intensities for each element in the
sample and for the same elements in calibration standards of known compositions [79].

Figure 17. Schematic drawing of the tear-drop model of the electron interaction volume and the
volume/depth from which the different signals originate [77].
The Hitachi® SEM SU800 was used to capture high quality images of mapping areas.
Elemental compositions of the primary and secondary phases of the grain structures were
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mapped using the attached EDS mapping feature. Almost all EDS mapping was conducted using
a working distance of 15.5 mm, and a voltage and current of10kV and 20µA respectively.
3.3 Mechanical Tests
Ascertaining the mechanical properties of fabricated materials is critical to alloy
developers, as well as to medical device designers. The objective of this testing was to
characterize the compressive and tensile behavior (Figure 18) at static conditions for the series of
magnesium alloys produced for this study to assess the mechanical integrity for each
formulation. When forces that are applied to a material are constant they are said to be static.
Material characteristics and mechanical strength were quantified and assessed for the potential
use as biomaterials in medical devices. All mechanical testing conducting on the Mg-based
alloys in this study were either outsourced to Orthokinetics Testing Technologies LLC, an ISO
17025 certified, A2LA accredited test facility or done in-house in accordance with ASTM E9-09,
“Standard Test Methods of Compression Testing of Metallic Materials at Room Temperature"
[80] and ASTM E8/E8M-11 “Standard Test Methods for Tension Testing of Metallic Materials”
[81] at North Carolina A&T State University Mechanical Testing Facility.
3.3.1 Compression testing. The properties of a material are determined from the
dimensions of the sample and the stress-strain diagram produced by the compression test.
Samples dedicated for the compression tests were cut into cylinders with dimensions of 10 mm
in diameter and 20 mm in height (Figure 19a). In static compression testing, the actuator of the
MTS electro-mechanical test machine was connected to the superior compression fixture which
held a stainless steel adaptor plate to the load cell. The test apparatus was assembled such that
the Z-axis of the device was collinear with the axis of the actuator and load cell of the testing
machine.
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Tension

Compression

Figure 18. Examples of tension and compression loading and their shear response [62].
When loaded, the actuator applied a resultant force to the specimen directed along the
longitudinal axis, which was aligned along the center of the circular cross-section plane of the
test specimen. After each compressive failure test, the test fixture was inspected to ensure the test
platen and components were not compromised or adversely affected by the previous test.
A compressive load was applied to each specimen mounted to the test machine at a rate of 2.0
mm/minute under displacement control until a failure was achieved. The test was stopped after
the onset of a failure mode, where a failure was defined as plastic deformation that rendered the
device ineffective or unable to adequately resist load, or permanent deformation resulting from
fracture. Such failure was designated as a reduction in the compressive force, or when the
superior and inferior fixtures made contact. All testing was conducted in ambient air at room
temperature. Load and displacement data were recorded throughout the test at a relevant
sampling rate. A laser extensometer was used to accurately track specimen deformation at
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precise markings on the test samples, as mechanical losses in the test system (crosshead and
fixtures) made crosshead displacements inconsistent. Figure 19b is a representative setup
configuration photo of the static compression test apparatus.
(a)

(b)

Figure 19. (a) Compression test sample and (b) static compression apparatus.
3.3.1.1 Modulus of elasticity. The modulus of elasticity is a material property that
quantifiably describes the tendency of a material to deform elastically when a stress is applied to
it. A uniaxial force is applied to the test specimen and the stress and strain were measured. The
engineering stress (σ) is determined by dividing the indicated force by the sample’s original
cross-sectional area (Equation 5). The engineering strain (ϵ) is defined as the difference between
the instantaneous length and the original length divide by the original (Equation 6). By
convention, a compressive force is taken to be negative, which yields a negative stress.
Furthermore, since lo is greater than li, compressive strains computed from equation 13 are also
negative.
/

σ0

1

Equation 5
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Equation 6

The appropriate slope is then calculated from the stress-strain curve (Figure 20) which is derived
from the test data [82]. For most metals, the strain is proportional to the applied stress which is
known as Hooke’s law (Equation 7), and the constant of proportionality E is the modulus of
elasticity.
σ  62

Equation 7

For this study, after the test data was imported into the processing software, the
engineering strain is set up as the x-axis (%) and the engineering strain is set up as the y-axis
(MPa). Once the stress-strain curve was constructed from the test data, the initial linear portion
of the curve is isolated and a linear line was fitted to the curve. The slope from the equation
derived from said linear line is determined which is the elastic modulus of the alloy.

Figure 20. Schematic stress-strain diagram showing linear elastic deformation for loading and
unloading cycles [64].
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3.3.1.2 Yield strength. In materials development, the design for the application of a
material usually ensures that only elastic deformation will result when a stress is applied.
Consequently, it is important to know the stress at which plastic deformation or yielding occurs.
For metals that experience this gradual elastic-plastic transition, the point of yielding may be
determined as the initial departure from linearity of the stress-strain curve; this is sometimes
called the proportional limit [64]. In most cases the position of this point may not be able to be
determined precisely, therefore the offset method is applied. The offset method is where a
straight line is constructed parallel to the elastic portion of the stress-strain curve at a specified
value (conventional offset is 0.002.) [64, 80]. The yield strength is defined as the stress
corresponding to the intersection of this parallel line and the stress-strain curve as it bends over
in the plastic region (Figure 21). The line mn is constructed parallel to OA, and is positioned at a
layoff position Om equal to the specified value of offset. Thus the intersection r between mn and
the stress-strain curve is the yield strength for the specified offset [80].

Figure 21. Stress-strain diagram for the determination of yield strength by the offset method.
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3.3.1.3 Ultimate strengths. For materials that fail in compression, the ultimate
compressive strength (UCS) and ultimate tensile strength (UTS) is the maximum stress that a
material can withstand before fracture on the stress-strain curve [80]. It is determined by dividing
the maximum load in compression (or tension) by the original cross-sectional area of the test
specimen. The ultimate strength is a key value for design of structure purposes.
3.3.2 Tensile testing. The most common of the static tests is the uniaxial tensile test,
which provides information about a variety of properties [62]. When a material is subjected to
tensile loading, the relationships between stress and strain are similar to those for a compressive
testing. Up to a certain value of stress, the material behaves elastically. Beyond this value, plastic
flow occurs. Static tension testing was performed on standard tensile test samples (Figure 22a).
The actuator of the electro-mechanical test machine was connected to calibrated high force MTS
wedge style tension gripping fixtures. Each test sample was inserted into the fixtures and
clamped securely. When loaded, the actuator applied a resultant force to the specimen directed
along the long axis and located at the center of the cross section of the specimen. The test
apparatus was assembled such that the z-axis of the device was collinear with the axis of the
actuator and load cell of the testing machine. After each tensile failure test, the test fixture was
inspected to ensure the grips and clamps were not compromised or adversely affected by the
previous test.
A tensile load was applied to each specimen loaded in the test machine at a rate of 1.3
mm/minute under displacement control until a failure was achieved. The test was stopped after
the onset of a failure mode, where a failure was defined as plastic deformation that rendered the
device ineffective or unable to adequately resist load, or permanent deformation resulting from
fracture. Such failure was designated as a sudden reduction in the tensile force, or when the
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specimen fractured and separated. Load and displacement data were recorded throughout the test
at a relevant sampling rate. A laser extensometer was used to accurately track specimen
deformation at precise markings on the test samples, as mechanical losses in the test system
(crosshead and fixtures) made crosshead displacements inconsistent.
(a)

(b)

Figure 22. (a) Tensile test sample and (b) static tension apparatus.
All testing was conducted in ambient air at room temperature. Figure 22b is a
representative setup configuration photo of the static tension test apparatus. The samples for
tensile tests are reduced ASTM flat shape (Figure 23) of 3 mm x 3 mm in cross section and 12.5
mm in gauge length (Figure 22a). A tensile load was applied to each specimen loaded in the test
machine at a rate of 1.3 mm/minute under displacement control until a failure was achieved. The
test was stopped after the onset of a failure mode, where a failure was defined as plastic
deformation that rendered the device ineffective or unable to adequately resist load, or permanent
deformation resulting from fracture. Such failure was designated as a `sudden reduction in the
tensile force, or when the specimen fractured and separated.
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3.3.2.1 Elongation. Ductility, which is the degree of plastic deformation that has been
sustained at fracture, is another important mechanical property that can be determined from a
tensile test (Figure 24). Ductility can be expressed quantitatively as percent elongation [64]. The
percent elongation (%∆L) is the percentage of plastic strain at fracture,
%∆L  

38 31
31

 9 100

Equation 8

where lf is the fracture length and lo is the original gauge length. A significant proportion of the
plastic deformation at fracture is confined to the neck region; the magnitude of %∆L will depend
on specimen gauge length. Since the elongation will vary with different gauge lengths, it is
important to remove the size effect to produce data that is characteristic of the given material and
not the particular specimen. The elongation is therefore divided by the original gage length to
eliminate the size effects [62]. Elongation is inversely proportional to hardness, elastic modulus,
and tensile strength. Meaning the greater a material’s hardness, modulus, and tensile strength, the
less it will elongate under stress.
L
B

A

B

C
G
R

t

Figure 23. Rectangular tension test specimen where A is length of reduced section, B is length of
grip section, C is width of grip section, G is gauge length, L is overall length, R is radius of filet,
t is thickness, and W is width [81].
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Figure 24. Schematic of a stress-strain diagram showing linear elastic deformation for loading
and unloading cycles [64].
3.4 Corrosion Assessment
Mg alloys exhibit an attractive commodity for industrial applications like the
automotive/transportation industries. Mg provides low weight, cost efficient solutions based on a
fully recyclable material [83]. Poor corrosion resistance of Mg alloys has been a major obstacle
to their widespread applications as structural materials [84]. The problem of metallic corrosion is
one of significant proportions; in economic terms, it has been estimated that approximately 5%
of an industrialized nation’s income is spent on corrosion prevention and the maintenance or
replacement of products lost or contaminated as a result of corrosion reactions [64]. However,
there is a growing interest in the medical community to use corrodible alloys in a number of
medical applications, due to their ability to degrade through corrosion reactions in the body fluid.
In vitro corrosion tests are cost effective, simple to construct, and helpful in predicting the
corrosion behavior of biodegradable materials.
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3.4.1 Galvanic corrosion. Corrosion is defined as the destructive and unintentional
attack of a metal. In terms of Mg, the most common form of corrosion that occurs in an aqueous
environment is galvanic corrosion. This form of corrosion occurs when the two metals or alloys
having different compositions are electrically coupled while exposed to an electrolyte [64].
During a galvanic reaction, the base metal or more reactive metal in the particular environment
will experience corrosion; the more inert or noble metal, the cathode, will be protected from
corrosion [64]. More specifically, one of the metals in the galvanic couple becomes the anode
and corrodes faster than it would by itself, while the other becomes the cathode and corrodes
slower than it would alone [85]. Metallic atoms characteristically lose or give up electrons in
what is called an oxidation reaction; the site at which oxidation takes place is called the anode
[64, 85]. For example, metal M with an n valance electron may undergo the following oxidation
reaction where M becomes positively charged and loses its n valance electron (Figure 25):
M ; M <= ' >? 

Equation 9

By convention, the electrons generated from each metal atom under oxidation must transfer to
and become a part of another element or compound which is said to undergo reduction. Some
metals corrode in acid solutions which have high concentrations of hydrogen ions that are
reduced and hydrogen gas is generated as follows (Figure 25):
2H = ' 2?  ; HA

Equation 10

The location at which this reduction occurs is called the cathode. For galvanic corrosion to occur,
three conditions must be present [85]:
1. Electrochemically dissimilar metals must be present
2. These metals must be in electrical contact, and
3. The metals must be exposed to an electrolyte
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Figure 25. The electrochemical galvanic reactions associated with the corrosion of hypothetical
metal M in an acid solution.
3.4.2 Immersion corrosion test. The two most common corrosion testing procedures
used to determine the in vitro corrosion rate of a biodegradable material are the electrochemical
method and the immersion corrosion test. However, the corrosion rate obtained from
electrochemical methods may be unreliable due to the negative difference effect (NDE) which
should be regarded as a common process in the corrosion of Mg [86]. The NDE effect is
essentially the effect that the measured hydrogen evolution is greater than the expected hydrogen
evolution. For most metals, the hydrogen evolution decreases with an increase of the applied
potential or current density. However, for Mg, it is found experimentally that, with increasing
potential, both the Mg corrosion rate and the hydrogen evolution rate increase [86]. This
electrochemical phenomenon causes the weight loss calculated with Faraday’s law is lower than
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the weight loss determined experimentally. Consequently, for this study, immersion corrosion
testing was utilized.
Immersion testing is one of the most frequently conducted experiments for evaluating the
corrosion of metals in aqueous solutions. The foundation of an immersion test is that a test
specimen is completely immersed in a corrosive solution for a set period of time and then the
specimen is removed and analyzed. However, a number of factors must be considered to achieve
specific goals and to ensure adequate reproducibility of test results. The actual conditions of the
test are usually determined by the nature of the problem at hand, the ingenuity of the
investigator, and the budget of the test program [87].
3.4.2.1 Test specimen preparation. Test specimens of each alloy were cut into 10
mm×10 mm×3 mm pieces and polished with 400, 600, 800, 1000, and 1200 grit carbide papers
and ultrasonically cleaned with acetone. Initial measurements of each specimen where recorded
which included the initial weight (g), thickness (mm), and surface area (cm2).
3.4.2.2 Test conditions. Two types of test solutions were used for the immersion tests.
The first type of solution was 0.9% NaCl physiological saline solution which consisted of 0.9%
NaCl per 1000ml of deionized water. The second type of solution was a cell culture medium
called Minimum Essential Medium Alpha (MEMα). Test specimens were individually placed
into containers and were filled with test solution based on the “solution volume-to specimen
area” ratio of 0.50 ml/mm2 [88]. Each container was then incubated at 37°C in humidified
atmosphere of 5% CO2 for 10 days. Specimens were removed from the container and immersed
in acetone to stop the corrosion process. Cleaning specimens post immersion testing is a vital
step in the corrosion test procedure and if not done properly, can cause misleading results [88].
Chemical cleaning was utilized for this study which is the removal of material from the surface
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of the test specimen by dissolution in a chemical solution. A chromic AgNO3 acid solution was
used to clean or remove all corrosion products from the test specimens. A “blank” specimen
which was not subjected to the immersion testing procedures of was weighed before and after
exposure to the cleaning procedure to establish and correct the mass loss created by the chromic
solution.
3.4.2.3 Corrosion rate. The corrosion rate, or the rate of material removal as a
consequence of the chemical reaction, is an important corrosion parameter in biomedical
material development. For this study, calculating the corrosion rate (mm/y) is based on the
following equation [88]:
Corrosion rate  JK 9 ∆LM⁄JN 9 O 9 PM

Equation 11

where K is the constant 8.76 × 104, to yield a mm/y unit for the corrosion rate; t is the time of
exposure in hours to the nearest 0.01 h; A is the total surface area in cm2 to the nearest 0.01 cm2;
∆W is the mass loss in g to the nearest mg (corrected for any loss during cleaning); and D is the
density in g/cm3.
3.5 Cytocompatibility Assessment
Alloying is used to alter the mechanical capabilities and corrosion behavior of Mg.
However this technique is restricted in the case of designing Mg alloys for biomedical
applications because the toxicity of alloying elements must be taken into account [89]. There are
two broad categories commonly used to assess the toxicity of biomaterials: in vitro and in vivo
toxicity testing.
In vivo (Latin for “within the living”) refers to experimentation using a whole living
organism as opposed to a partial or dead organism [90]. Animal studies and clinical trials are two
forms of in vivo testing. In terms of implant materials, in vivo testing is used to determine the
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biocompatibility of a material. Animal studies are generally adopted by the Globally Harmonized
System (GHS) classification and human health risk assessments [91]. FDA clearance of new
products or devices to be used in clinical applications requires in vivo animal testing to provide
information that demonstrates it is as safe and effective as predicated. Even though in vivo
assessment is important to determining the biocompatibility of an alloy, increasing societal
concerns about animal use and the high cost of conducting regulated animal tests have rendered
the need of alternative in vitro test methods that can reduce the use of animal testing for acute
systemic toxicity testing.
In vitro (Latin for “within the glass”) refers to the technique of performing a given
procedure in a controlled environment outside of a living organism [90]. Cellular biology utilizes
this technique to conduct experiments using living cells grown outside of a living organism. In
terms of implant materials, in vitro testing is used to determine the cytocompatibility of a
material. Cytotoxicity is the quality of being toxic to cells [92]. Cells exposed to a cytotoxic
compound can react in a variety of ways which include loss of membrane integrity, hindered cell
proliferation, and apoptosis. In vitro cytotoxicity assays are a good tool for initial material
screening. This type of testing has a great potential for reducing and refining traditional in vivo
toxicology tests [91]. However, one major inherent limitation of in vitro testing is the inability to
replicate precise cellular conditions of an organism which leads to results that do not correspond
to in vivo results [72, 90]. As a result of this limitation and the restrictions applied by regulatory
institutions, in vivo animal testing is still considered the gold standard in assessing the
biocompatibility and safety of a material to be used in biological systems. The advantages of in
vitro testing is the significant simplification of a complex biological system which a number of
small components throughout the system can be focused upon, reduced costs through cost-
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effective testing compared to in vivo studies, and an alternative method which can provide
benefits in terms of ethical considerations that are seen which animal and human testing [90, 93].
Considering the information discussed above, Live/Dead and MTT in vitro cell viability
assays were used to determine the cytocompatibility of the alloys produced in this study.
3.5.1 Cell culture procedure. The MC3T3-E1 pre-osteoblast cell line (American Type
Culture Collection, Manassas, VA USA) was adopted for the cell viability assessment of this
dissertation. MC3T3-E1cells are obtained by the cloning of cells isolated by collagenase
digestion of newborn mouse calvarias [94]. Cloned MC3T3-E1 cells isolated from newborn
mouse calvarias retains an ability to differentiate into osteoblastic cells in vitro which ultimately
form bone-like ossicles [95]. The MC3T3-E1 cells were cultured in 75 cm2 tissue culture flasks
in a complete growth alpha minimum essential medium (MEMα) which consisted of 10% fetal
bovine serum and 1% penicillin/streptomycin and incubated in a humidified atmosphere of 5%
CO2 at 37°C. The cells were sub-cultured every 4 to 5 days using 0.25% (w/v) trypsin – 0.53
mM EDTA solution and fresh medium was added every 2 to 3 days.
3.5.2 Live/dead assay. The Live/Dead assay is a two-color fluorescence viability assay
that is based on the simultaneous determination of live and dead cells with two probes that
measure intercellular esterase activity and plasma membrane integrity. This type of assay
characterizes metabolically active cells from injured or dead cells. Live cells are distinguished by
the presence of universal intracellular esterase activity. The colorless calcein acetomethoxy
(calcein AM) dye is retained and metabolized by live cells, producing an intense uniform green
fluorescence. The ethdium homodimer-1 (EthD-1) enters cells with damaged membranes and
undergoes a 40-fold enhancement of fluorescence upon binding to nucleic acids, thereby
producing a bright red fluorescence in dead cells.
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For this study, Mg alloys were cut and polished with 400, 600, and 800 grit carbide
papers and ultrasonically cleaned with acetone. Each individual Mg samples was sterilized on
both sides with ultraviolet light (UV) for 15 minutes. The samples were placed in containers and
immersed in MEMα, according to the extract ratio given in the “Biological evaluation of medical
devices: Sample preparation and reference materials” ISO standard [96], and incubated in
humidified 5% CO2 atmosphere at 37°C for 72 h. The samples were removed from the solution
and the extract MEMα solution was sterilized via 0.2 µm filtration. For exposures, the MC3T3E1 cells were incubated with the extract solution at a concentration gradient of 100%, 50%, 25%,
and 10% for 24 and 72 hours. The extract solutions were removed from the cells and the cell
surfaces were washed with phosphate buffered saline (PBS) and the dye solution was seeded
over the cells and placed in the dark for 30 minutes. Dye solution consists of 2 nM of calcein
AM and 4 nM of EthD-1 in PBS. Fluorescence optical microscopy was used to take images of
each well using the EVOS® FL Cell Imaging System.
3.5.3 MTT assay. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide)
is a water soluble membrane permeable dye which is metabolized to dark-purple crystals of
formazan by mitochondrial dehydrogenases of living cells [97]. These crystals are impermeable
to cell membranes and are accumulated in proliferating, undamaged cells. After lysis of the cell
and solubilization of the formazan crystals, the optical density (OD) of the dye is quantified
using a multi-well-spectrophotometer (SpectroMax M5 microplate reader) at around 550 nm.
The number of proliferating cells is directly proportional to the development of dark-blue
crystals and can be quantified by means of a standard calibration. Since the total mitochondrial
activity is related to the number of viable cells, the MTT assay is broadly used to measure the in
vitro cytotoxic effects of foreign compounds on cell lines or primary patient cells [97].
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Each sample purposed for the MTT assay were prepared and sterilized, as discussed in
section 3.5.2, immersed in MEMα according to the extract ratio given in the “Biological
evaluation of medical devices: Sample preparation and reference materials” ISO standard [96] ,
and then incubated at 37°C in a humidified atmosphere of 5% CO2 for 72 hours. Extract
solutions were sterilized via 0.2 µm filtration. For exposures, the MC3T3-E1 cells were
incubated with the extract solution at a concentration gradient of 100%, 50%, 25%, and 10% for
24 and 72 hours. The MTT reagent was dissolved at 5 mg/ml in PBS and then diluted at a 10 to 1
ratio with MEMα media. The extract was removed from cells and the cells were washed with
fresh media. The MTT/media mix was transferred to each well to yield a final volume of
110µl/well. Plates were incubated for 4 hours at 37°C and 5% CO2. A sodium dodecyl sulfate
(SDS) solution mix, which consists of 1g of SDS and 10ml of 0.01M hydrochloric (HCL) acid,
was added to each well at a volume of 100µl and incubated for 16 hours. Absorbance was read at
570 nm using a Spectromax M5 microplate reader. The evaluation of the MTT assay was based
on the percent of metabolic activity (Equation 12) of cells after 24 and 72 hours of incubation.
% of Metabolic Activity 
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Equation 12

3.6 Statistical Analysis
For all quantitative outcomes of this study, the one-way or two-way analysis of variance
(ANOVA) statistical analysis methods were applied to scrutinize the data. The analysis of
variance is a statistical method used to test differences between two or more means. ANOVA is
used to test general rather than specific differences among means [98].
3.6.1 One-way ANOVA. One-way ANOVA, also called one-factor ANOVA, compares
three or more sets of measurements. For example, a study might assess the effect of one
particular clinical drug on male and female rabbits. In this example, the one-way ANOVA allows
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the study to be broken into groups according to the rabbits and then see if the effect of drug
treatment is different across the rabbits. A one-way ANOVA test is chosen when [99]:
•

A variable is measured in each subject several times, perhaps before, during, and after an
intervention.

•

A subject is recruited as matched groups, matched for variables such as age, ethnic group,
and disease severity.

•

An experiment is run several times, each time with several treatments handled in parallel.

Since experiment-to-experiment variability is anticipated, the data will be analyzed in such a way
that each experiment is treated as a matched set. Matching should not be based on the variable
you are comparing. If you are comparing blood pressures in three groups, it is OK to match
based on age or zip code, but it is not OK to match based on blood pressure [99].
3.6.2 Two-way ANOVA. The two-way ANOVA, also called two-factor of variance,
determines how a response is affected by two factors [99]. If an experiment has a quantitative
outcome and two categorical explanatory variables that are defined in such a way that each
experimental subject can be exposed to any combination of one level of one explanatory variable
and one level of the other explanatory variable, then the most common analysis method used is
two-way ANOVA [100]. For example, a study might assess the effect of three different types of
clinical drugs in both male and female rabbits. In this example, the drug treatment is one factor
and the gender of the rabbits is another. Two-way ANOVA simultaneously asks three questions:
1. Does the first factor systematically affect the results?
2. Does the second factor systematically affect the results?
3. Do the two factors interact?
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When interpreting the results, the two-way ANOVA utilizes the p-value to answer the question:
If the null hypothesis is true, what is the chance of randomly sampling subjects and ending up
with as much of an interaction than you have observed [100]? When performing a hypothesis test
in statistics, the p-value helps determine the significance of the results [101]. The p-value is a
number between 0 and 1 and interpreted in the following way:
•

A small p-value (typically ≤ 0.05) indicates strong evidence against the null hypothesis, so
you reject the null hypothesis.

•

A large p-value (> 0.05) indicates weak evidence against the null hypothesis, so you fail to
reject the null hypothesis.

•

p-values very close to the cutoff (0.05) are considered to be marginal (could go either way).

The two-way ANOVA reports three p-values:
1. Tests the null hypothesis that time has no effect on the outcome.
2. Tests the null hypothesis that the treatment makes no difference on average.
3. Tests for interactions.
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CHAPTER 4
Results and Discussion
This chapter presents the collection of qualitative and quantitative results produced from
the experimental methods and concepts described in the previous chapter and their interpretation.
The results are categorized according to experiment type and alloy composition. The results will
include microstructural assessment, mechanical testing analysis, corrosion assessment, and
cytocompatibility evaluation.
4.1 Microstructure and Phase Constitutions
4.1.1 As-cast MgZnCa alloys. The composition of the alloying elements were measured
by SEM-EDS analysis which was accomplished to provide detail about the alloy’s actual
composition after casting which is described in Table 7 (Appendix). In all cases the actual
composition of the Zn and Ca elements were more compared to the nominal composition.
Conversely there is a 1−2% loss of magnesium which could be a result of a common
phenomenon called “melting loss”. Depending on the volume of throughput and furnace design,
high melt losses are often encountered in melting operations. As reported in the experimental
methods and concepts section (Chapter 3), the Mg melt was stirred at a specified temperature
above 700°C after the addition of alloying elements. This has to be regarded as critical for the
protective Ar gas because its efficiency may be reduced at these temperatures [102]. As a result,
a certain amount of Mg can react with the environment and the components of the protective
gases. This leads to the formation of magnesium oxides and dross which can be incorporated into
the casting.
4.1.1.1 Grain structure analysis. The as-cast Mg−xZn−0.3Ca alloy grain structures are
illustrated in Figure 26. The grain morphology is observed to be typically hexagonal globular in
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nature. It can be observed that the level of zinc content has an influence on the grain structure
because the intermetallic phase observed along the grain boundaries and within the grains
become more potent and the eutectics are thickened as the zinc concentration increases. The
intermetallic secondary phase is found to be rich in both Zn and Ca which is supported by the
SEM-EDS elemental mapping images in Figure 27.
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Figure 26. Optical micrographs of as-cast Mg−xZn−0.3Ca alloy grain structures.
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Figure 27. SEM images and EDS elemental mapping images along the grain boundaries of the
as-cast Mg−xZn−0.3Ca alloys.
4.1.1.2 Phase constitution. Through EDS compositional analysis, the intermetallic
secondary phases are identified and presented in Figure 28. For the M-46 and M-47 samples, the
dominate phase detected was the α−Mg matrix. The solute elements are all dissolved into the Mg
matrix and no intermetallic precipitates appear in grain boundaries.
Based on the cooling curves developed by Bakhsheshi-Rad et al. [103], during
solidification the primary α−Mg phase is initially formed. As the temperature of the molten metal
decreases, there is a rejection of alloying elements from the α−Mg dendrite at the liquid-solid
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interface which causes an increase in the Ca concentration in the solid formed from residual
liquid among the Mg dendrite network. CaMg2 secondary phase starts to precipitate along the
grain boundaries as the temperature decreases. The last stage of the solidification process caused
the appearance of the Ca2Mg6Zn3 intermetallic phase [103].
Both the CaMg2 and Ca2Mg6Zn3 phases were detected in the M-48 alloy. This is in
agreement with the ternary phase diagram presented in Figure 29. For the M-49 thru M-52
alloys, the main phase detected was the Ca2Mg6Zn3 phase which similar to what Hradilová et al.
and Kubok et al. found in their investigation of the Mg−4.0Zn−0.4Ca and Mg−3.0Zn−0.5Ca
(wt.%) systems, respectively [74, 104]. Additionally, Sun et al. [44] prepared an
Mg−4.0Zn−0.2Ca alloy for their investigation which underwent XRD scans to examine the
phase of the as-cast alloy from 20 to 90° with a step size of 0.05. Peaks from the α-Mg and the
Ca2Mg6Zn3 phase was detected, as well as peaks from the Ca2Mg5Zn13 phase. There is no
indication of the CaMg2 phase within M-49 thru M-52 alloys. The higher concentration of Zn
(3−6 wt.%) caused the suppression of the CaMg2 phase suggesting the following solidification
process [103]:
L → α−Mg + Ca2Mg6Zn3

Equation 13

The MgZn phase was also detected within these alloys starting at the M-50 sample. For
the M-53 alloy, a new phase was discovered (Mg12Zn13) in addition to the α−Mg and Ca2Mg6Zn3
phase. This phase differs from the Mg51Zn20 phase in which Bakhsheshi-Rad et al. discovered for
their alloy with Zn content of 9 wt.%. It is also noticed that with the increase of Zn, the
predominant phase of the intermetallic region shifts from Ca2Mg6Zn3 to MgZn/Mg12Zn13 which
is in agreement with previous studies [103] and the solidification process described in Equation
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13. It is also observed that a lamellar eutectic structure starts to develop at the 4.0 wt.% Zn
concentration.
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Figure 28. SEM micrographs of as-cast Mg−xZn−0.3Ca alloys detailing the specific phases
along the grain boundary and within the Mg matrix.
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Figure 29. Calculated isothermal section of the Mg−Ca−Zn system at 335°C with two ternary
compounds compared with experimental data of [105] where A denotes: Ca2Mg6Zn3 and B
denotes: Ca2Mg5Zn13 [106].
4.1.1.3 Grain size analysis. The average grain diameter (µm) of the as-cast
Mg−xZn−0.3Ca samples, which were counted from the OM images utilizing the ASTM line
intercept method [75], are described in Figure 30. The samples were compared to an Mg−0.3
wt.%Ca sample with no Zn addition to get a better understanding of the effects of adding Zn to
the Mg−Ca system in terms of the grain size. Ca is commonly known to provide grain refinement
to Mg alloys, but for this study all alloys have the same weight percentage of Ca (0.3 wt.%).
Consequently the amount of Zn is the underline factor in the grain size difference between the
alloys.
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Figure 30.. Average grain diameter in µm of as-cast Mg−xZn−0.3Ca samples compared with the
Mg−0.3Ca system determined from the ASTM line intercept method.
The one-way ANOVA statistical analysis was conducted to compare the significance
between the average grain diameters of the as-cast Mg−xZn−0.3Ca samples. From the one-way
one
ANOVA analysis, it was determined that there was a significant difference in the average means
of the grain diameters at the p < 0.05 level [F(8, 495) = 18.45, p < 0.0001]. From this
information it can be concluded that the effects of the level of Zn concentration on the average
grain diameter were substantial
tial and not created by chance. There is no significant difference
found between the average grain size of the Mg
Mg−0.3Ca sample (152.8 ± 134.8 µm) and the M-46
M
(192.3 ± 113.1 µm) and M-47 (123.0 ± 81.0 µm) samples. The grain size reduction doesn’t
significantly occur until the Zn level reaches 22.0 wt.% in which the grain diameter average starts
reduce to the lowest points at M--49 and M-50
50 in which the grain size is 60.97 ± 30.4
3 µm and
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69.2 ± 38.4 µm respectively. The grain size reduction as a function of the Zn level increase is in
agreement with Bakhsheshi-Rad et al. [103] who found that the addition of Zn from 1 to 3 wt.%
in the ternary Mg−xZn−Ca alloy caused grain refinement.
When examining the reason behind the reduction of grain size diameter as a function of
the increase in Zn concentration, it is pertinent to understand the solidification process. The
solidification of a solid transpires by nucleation and growth. The key solidification processes that
control the final microstructure are the initial nucleation events, the growth of these nuclei into
primary dendrites and finally eutectic solidification [107]. When a metal solidifies, small
particles of solid forms from the molten liquid which act as a nucleus site and grow as other
atoms attach themselves to this solid nucleus site to create a crystal or grain. The size of the
grains in a metal vary with the rate of nucleation and the rate of growth [62]. The greater the
nucleation rate, the smaller the resulting grains and inversely the greater the rate of growth, the
larger the grains. For the Mg−Zn system, Huan et al. [89] explained that Zn content closer to the
maximum solubility in Mg (6.2 wt.% at 635°C) leads to more MgZn precipitates under the
equilibrium conditions and Wasiur et al. [106] discovered that the addition of Zn in a Mg−Ca
alloy system creates the refinement of precipitates as well. Therefore, it is believed that there is
higher precipitation of Zn from 0.5 to 4 wt.% which provides more nucleation sites which can
cause an increase in the number of grains resulting in smaller grains. Therefore, the addition of
Zn can refine the grains and introduce more secondary phases which is in agreement with Du et
al. [25]. The average grain diameter fluctuates from M-51 to M-53. The one-way ANOVA has
the ability to compare each individual mean with one another and it was determined that from M50 to M-53 there were no significant difference excluding M-51 as an outlier.

74
These grain size results are based on one sample extracted from the bulk of each
individual as-cast alloy. Each grain measurement was acquired along the surface of the sample
cut in one direction. To determine reproducibility, more samples must be taken at from the bulk
of each alloy and grain size measurements must be determined from the surface of each sample
cut in many directions. The same limitation is found in the grain size analysis throughout this
study.
4.1.2 Heat treated MgZnCa alloys. After determining the grain size of the as-cast
Mg−xZn−Ca alloys, the next step was to perform additional processing techniques in the way of
heat treatment processing to analyze its effect upon the as-cast alloys. The M-49 and M-50
samples were selected for undergoing additional T4 heat treatment processing.
4.1.2.1 Grain structure analysis. The nominal compositions of the M-49 and M-50
samples were Mg−3.0wt%Zn−0.3%Ca and Mg−4.0wt%Zn−0.3%Ca respectively. To determine
the optimum temperature and time combination to have successful heat treatment outcomes,
several different treatment parameters were explored. The first double stage heat treatment
combination of parameters considered was at 300°C for 20 h and then 400°C for 2, 4, 6, and 8 h
which was performed on the M-50 sample. OM images were taken of the T4 heat treated M-50
alloy which is illustrated in Figure 31. No strong oxidation or heat treatment defects were
observed after heat treatment. Descriptive evidence suggests that when heat treatment is applied,
the secondary phase along the grain boundary and within the inner grains is more refined than
the as-cast counterpart. This is supported by the average area of the secondary phase of the ascast M-50 sample compared to the heat treated samples (Figure 32). The average area of the
secondary phase was determined from OM images of the heat treated M-50 samples (n = 3)
taken at 5x magnification.
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Figure 31. Optical micrographs of the grain structures of the M-50 samples that were T4 heat
treated at 300°C for 20 h and then 480°C for 2, 4, 6, and 8 h.
The one-way ANOVA determined that there was a significant reduction of the secondary
phase after heat treatment compared to the as-cast sample [F(4,10) = 17.15, p = 0.0002]. The
purpose of the solution heat treatment process is to dissolve constituent atoms into the base
metal. This process is accomplished by diffusion, which is the phenomenon of material transport
by atomic motion [64]. Diffusion requires enough energy to overcome the energy barrier needed
for atoms to migrate from lattice site to lattice site. Based on the atomic radii of Mg (141pm), Zn
(122pm), and Ca (176pm), the type of diffusion occurring in the Mg−xZn−0.3Ca system of this
study is substitutional diffusion. In substitutional diffusion, there must be an empty adjacent
lattice site for atomic motion to occur. The simplest case of substitutional diffusion is selfdiffusion which occurs for pure metals.
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Figure 32. Average area of intermetallic phase of as-cast and heat treated (300°C 20 h + 480°C
xh) M-50 samples taken from OM images at 5x (n = 3).
During self-diffusion all atoms are chemical identical and this leads to a simple
relationship between jump frequency and diffusion coefficient. In binary alloys, this relationship
is more complex. The rate at which solvent and solute atoms can move into a vacant site is not
equal and each atomic species must be given its own diffusion coefficient [108]. At a specific
temperature, however, some small fraction of the total number of atoms is capable of diffusion
based on their vibrational energies which increase with rising temperature [108]. The addition of
a third diffusing component, i.e. ternary alloys, to a solid solution produces even more
complexities because the behavior of two solutes must now be consider. When comparing the
HCP structure of Mg and Zn to other various materials, the activation energy needed for
diffusion to occur is lower than most atomic structures (Figure 58b, Appendix). Therefore the
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heat treatment temperature coupled with the relatively low treatment time was able to activate
the solute atoms enough for diffusion to occur which explains the significant decrease in
secondary area compared to as-cast M-50 samples.
In terms of the effect of the treatment time on the efficiency of diffusion of the secondary
phase, there is no statistical significant difference between each heat treated samples. This
suggest that an extended solution treatment time must be studied further to get a better
understanding of the effects of treatment on the dissolution of the secondary phase trend.
4.1.2.2 Grain size analysis. Figure 33 describes the average grain diameter in µm of the
heat treated M-50 samples compared to the as-cast M-50 samples which were counted from the
OM images. The one-way ANOVA statistical analysis was conducted to compare the effects of
the heat treatment on the average grain size. From the one-way ANOVA analysis, there was a
significant difference in the average means of the grain diameters at the p < 0.05 level [F(4, 217)
= 19.71, p < 0.0001]. From this statistical information it can be concluded that the effects of the
heat treatment on the average grain diameter were substantial. More specifically, there is an
increase in the average grain diameter once heat treatment is introduced to the M-50 samples.
The average grain size of as-cast M-50 is 69.2 ± 38.4 µm. All heat treated M-50 samples show
an increase in average grain size than that of the as-cast M-50 sample, suggesting that the
introduction of this solution treatment increases the average grain size. Due to the relatively high
temperatures used for the heat treatment processing, most of the secondary phase at the grain
boundaries dissolved into the Mg matrix and as a result the grains grew. It can be seen that there
was an initial increase in average grain size diameter as the treatment time increased until the
grain size reached its apex of 170.4 ± 81.7 µm at a treatment time of 4 h. There is a slight
reduction of grain size thereafter as the heat treatment time increases from 4 hours to 8 hours.
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Figure 33.. Average grain diameter in µm of heat treated (300°C 20 h + 480°C xh)
h) M-50
M
samples
compared with as-cast M-50
50 samples determined from the ASTM line intercept method.
However, the one-way
way ANOVA also compared each heat treated sample to one another
and determined that there is no significant ddifference in the means. This suggests that the
treatment time used for thiss experiment does not have a significant effect on the average grain
size. Therefore an extended solution treatment time must be considered.
4.1.2.2.1 Knowledge gained through literature review
review. Alvarez-Lopez et al. [109]
discovered that the best corrosion behavior of the AZ31 alloy corresponds with finer grain size in
PBS. This is accredited to a more negative corrosion potential and the formatio
formation
n of a layer of
corrosion products which offers more protection from the diffusion of ions to the electrode
surface. Similarly, Estrin et al. [110
110] concluded from open
en circuit and potentiodynamic
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polarization tests in 0.1M NaCl solution, that pure Mg experiences a decrease in the corrosion
current with decreasing grain size which indicates better corrosion resistance. Even though there
is successful integration of the secondary phase within the Mg matrix of the heat treated M-50
samples in this study, it can be seen that either the heat treatment temperature or the insufficient
length of time causes a coalescence in grains which creates larger grain size that could be
detrimental to its corrosion resistance. Mg alloys tend to corrode rapidly in physiological
environment which creates a loss of mechanical integrity before the required time needed for
bone tissue healing, which makes this first set of M-50 heat treated alloys unattractive to be used
as implantable biomaterials. Therefore it was determined that there is a need to alter the heat
treatment parameters to create a microstructure that will yield more favorable results.
4.1.2.2.2 Heat treatment trial II. Therefore a second trial run of T4 heat treatment
conditioning was conducted. The double stage heat treatment temperature and time for this trial
was altered from the first trial to 320°C for 24 h and then 400°C for 24 h, 48 h, 72 h, and 96 h.
This process was conducted on both the M-49 (Zn = 3.0%) and M-50 (Zn = 4.0%) alloys.
In terms of the effect of this treatment parameter on the M-49 samples, it can be seen that
the grain microstructure is altered as the treatment time increases (Figure 34a-d). For the M-50
samples, it is not as visually profound to discern the alteration of the grain structure by the heat
treatment processing (Figure 34e-h). These two observations are supported by the reduction of
secondary phase’s graphs shown in Figure 35. It was determined that for the M-49 alloy, there
was a significant reduction of intermetallic phases as the treatment time increased from 24 h to
96 h. More specifically, once this heat treatment procedure is introduced to the M-49 alloy, the
secondary phase does not start to significantly reduce until the heat treatment time of the second
stage extends to 48 h.
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Figure 34. Optical micrographs of T4 heat treated M-49 and M-50 grain structures conducted at
320°C for 24 h and then at 400°C for 24, 48, 72, and 96 h.

Since the temperature of the second stage was reduced from 480°C to 400°C, the time
needed for atom diffusion extends from just 2 h to 48 h. This holds true when analyzing the
average grain diameter (Figure 36a).
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Figure 35.. Average area of intermetallic phase of heat treated (320
(320°C 24 h + 400°C
400 xh) samples
compared to the as-cast counterpart taken from OM images at 5x (n = 3): a) M-49
49 and b) M-50.
M
The as-cast M-49
49 samples and the 224 h heat treated samples has an average grain size of
61.0 ± 30.5 µm and 72.55 ± 34.2 µm, respectively. It is not until the treatment time reaches 48
4 h
you see a significant increase in the av
average
erage grain size (165.1 ± 95.6 µm). Regardless, the

82
extended treatment time of 48 h at 400°C is effective in dissolving the constituent phases into the
primary matrix, but it also promotes grain growth. When studying the effect of the heat treatment
times on the area of the secondary phase, statistical analysis discovers that between the 24 h and
48 h treatment, there is no significant change. This holds true for 24 h compared to the 72 h
treatment as well. It is not until you compare the 24 h to the 96 h treatment time there is a
significant difference in the reduction of secondary phase.
The effect of treatment time on the average grain size of the M-49 alloy does not show a
consistent trend. At the 72 h treatment time mark, there is a significant reduction of the average
grain diameter compared to the 48 h samples to 70.6 ± 35.4 µm, which is close to that of the ascast M-49 samples. It can be seen that even though there isn’t a significant change in the amount
of secondary phase between the 48 h and 72 h samples, from the OM images you can see a
significant morphological change in that the secondary phase along the grain boundaries have a
fine and consistent in size type of quality in their appearance suggesting grain refinement. Yet,
this refinement continues as the treatment time increases to 96 h where the diffusion of the
secondary phase causes grain assimilation which explains the increase in grain size and
secondary phase area reduction of the 96 h heat treated samples. This inconsistent grain size
trend may be attributed to error in sampling. More specifically the specimen used for
microstructural analysis of the bulk M-49 alloy could have been extracted from an area within
the bulk alloy that was inconsistent with specimens taken from other alloys. Therefore sampling
needs to be more standardized in the future to promote consistency and reduce error.
For the M-50 alloy, the heat treatment process reduces the area of intermetallic phase 10
percentage points compared to the as-cast samples (Figure 35b).
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Figure 36.. Average grain diameter in µm of heat treated (320°C 24 h + 400°C xh)
h) samples
compared with as-cast
cast samples determined from the ASTM line intercept method: a) M-49
M
and
b) M-50.
After the initial reduction of intermetallic phases, the reduction levels off with no
significant variation between the heat
heat-treated means following an extended heat treatment time.
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Additionally, as the secondary phase diffuse into the Mg matrix once heat treatment is applied,
the grain size consequently increases as the grain boundaries disappear which cause grain
assimilation as seen in the M-49 heat treated samples (Figure 36b).
4.1.2.2.3 Comparison between heat treatment trial I and II. To get a better understanding
of how the first heat treatment trial (300°C 20 h + 480°C xh) compares with the second heat
treatment trial (320°C 24 h + 400°C xh), the secondary area and grain diameter of each trial was
compared by their consecutive time points for the M-50 alloy (Figure 37). The two-way
ANOVA analysis for the average area of secondary phase determined that there is a no
significant difference between the two trials [F(3, 16) = 0.83, p = 0.4947]. The means for last
time point for each trial only had a difference of 0.59 percentage point. Additionally, the average
grain diameter for each trial shows an increase in grain size compared to the as-cast samples. The
two-way ANOVA also discovered that the difference between the means of the grain diameter
for both trials are not significant [F(3, 32) = 0.44, p = 0.7249].
For the M-50 alloy, the lack of significant statistical difference between both treatment
trials indicates that the treatment parameters did not create a meaningfully different alloy in
terms of the microstructure which will ultimately create different corrosion and mechanical
properties. There is a need for further optimization of the treatment parameters.
4.1.2.2.4 Heat treatment trial III. Consequently, a third T4 solution treatment trial was
considered for both the M-49 and M-50 alloys. The first stage of the treatment process consisted
of a temperature and time of 300°C for 48 h. The time of the first stage was increased from 24 h
to 48 h to further bolster the grain boundaries to prevent melting during the higher temperature
parameters experienced during the second stage which will help maintain grain size. The second
stage consisted of a temperature of 450°C for 72, 96, 120, and 144 h. The second stage
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temperature was increased from 400
400°C to 450°C
C because of the need to create more refined grain
structure among secondary phase.

Figure 37.. Comparison between heat treatment trial I (300
(300°C 20 h + 480°C xh)
h) vs. heat treatment
trial II (320°C 20 h + 400°C xh) which were conducted on the M-50 alloy.
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Figure 38. Optical micrographs of T4 heat treated M-49 and M-50 grain structures conducted at
300°C for 48 h and then at 450°C for 72, 96, 120, and 144 h.
Figure 38 shows the optical micrographs of the grain structures of the M-49 and M-50
samples subjected to the third T4 solution treatment trial. As seen in the as-cast and heat treated
alloys previous discussed in this study, the grain morphology of both alloys is observed to be

87
typically hexagonal globular in nature. Furthermore, the treatment conditions were effective in
reducing the secondary phase through diffusion for both alloys into the
he Mg matrix but there is
still no significant difference in the means when comparing the treatment times (Figure
(
39).

Figure 39.. Average area of intermetallic phase of as
as-cast and heat treated (300°C
C 48
4 h + 450°C
xh) samples taken from OM images at 10x (n = 3): a) M
M-49 and b) M-50.
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Again, the extended heat treatment time significantly increased the average grain size for
both alloys compared to the as-cast
cast samples ((Figure 40). There is no difference in grain diameter
between the treatment times as well.

Figure 40.. Average grain diameter of heat treated (300
(300°C 48 h + 450°C xh)
h) samples compared
with as-cast
cast samples determined from the ASTM line intercept method: a) M
M-49
49 and b) M-50.
M
Ultimately all three heat treatment trials were effective in diffusing the solute atoms into
the primary matrix based on the area of secondary phases observ
observed
ed on the OM micrographs.
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However, this diffusion caused grain integration which increased grain size. The larger grain size
is considered to be harmful to the corrosion resistance of metallic alloys. Lower corrosion
resistance can have an effect on the mechanical integrity of biomaterials designed for medical
applications. Only two heat treatment conditions were able to maintain grain size compared to its
as-cast counterparts which were the 320°C 24 h + 400°C 24 h and the 320°C 24 h + 400°C 72 h
M-49 samples.
4.1.3 As-cast and heat treated MgZnCa−RE alloys. The microstructures of the as-cast
and heat treated Mg−2.0Zn−0.3Ca−2.0RE alloys are summarized in Figure 41. The as-cast grain
morphology consisted of a rosette-like structure composed of dendrites of α-Mg matrix separated
by interdendritic phases. By EDS spectra analysis, the typical composition of secondary phase
for the as-cast alloy is determined to be approximately (mass fraction, %)
45.2Mg24.8Zn15.5Nd9.6Gd corresponding to the molar composition of Mg74.8Zn15.2Nd4.3Gd4.2.
The double stage heat treatment process was conducted at 400°C for 20 h and then 500°C
for 2, 4, 6, 8 h. The heat treatment process changed the grain morphology to a more refined
hexagonal globular structure. It can be observed that there is no change in the grain morphology
between the different heat treatment conditions. The secondary phases significantly dissolve into
the Mg matrix as a result of the heat treatment conditioning. Consequently, the heat treatment
created a single phase type of microstructure.
There is a significant 5 point percentage reduction in the average area of secondary phase
between the as-cast and the 400°C 20 h + 500°C 2 h condition (Figure 42a). The final heat
treatment condition at 8 h dissolves the secondary phase down to 1.3% of the area. The heat
treatment conditions were considerably effective in dissolving the solute elements as seen by the
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immediate effect of the lower treatment time on the reduction of the amount of secondary phase
along the grain boundaries and within the Mg matrix.
as-cast

2h

4h

200µm

200µm

200µm

8h

6h

200µm

200µm

Figure 41. Optical micrographs of MgZnCa−RE alloy grain structures in the as-cast condition
and the heat treated conditions at 400°C for 20 h and then 500°C for 2, 4, 6, and 8 h.
This is due to the normalized activation energy required for material diffusion. The
activation energy of rare earth metals is even lower than that of the HCP and FCC type structures
(Figure 58b, Appendix). Consequently, the dissolution of solute atoms within the Mg matrix of
the MgZnCa−RE alloy in this study was able to be fulfilled at the relatively short solution time
and solution temperature.
It can be seen that the REEs have a grain refining effect on the Mg−2.0Zn−0.3Ca alloy
since average grain diameter of the as-cast MgZnCa−RE alloy (32.6±13.9 µm) in this study is
considerably lower than the as-cast M-48 samples (75.1±42.4 µm) with no REEs. This is in
agreement with other studies which have shown that increasing the concentration of Nd and Gd
in Mg alloys reduces the grain size significantly [50, 111]. Additionally, REEs plays an
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important role in restricting grain growth during solution treatment which is seen in the results of
this study (Figure 42b).

Figure 42.. Average area of secondary phase (a) and average grain size diameter (b) of the as-cast
as
and heat treated MgZnCa−RE
RE alloy.
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It is determined in this study that there is no significant difference in the average grain
size means of the heat treated MgZnCa−RE alloys compared to the as-cast samples. Ning et al.
[111] explains that the precipitation of Nd from the Mg matrix during solution treatment is
distributed within and along the grain boundaries which act as an effective barrier for grain
integration during heat treatment. Furthermore, it is explained that grain growth occurs at low Nd
additions (0.21%) after heat treatment, while higher Nd addition alloys only had moderate
increase in grain size. It can be concluded that the T4 solution treatment conducted on the
MgZnCa−RE alloy was successful based on the grain restriction behavior exhibited in the heat
treated MgZnCa−RE alloys in this study coupled with the successful dissolution of solute atoms
in the Mg matrix. According to the microstructure and grain structure assessment in this study,
the MgZnCa−RE has great potential of being a successful biomaterial.
4.2 Mechanical Properties
For bone implant, mechanical integrity is a vital component of the implant material.
Figure 43 shows the tensile test results at room temperature of selected investigated alloys. The
alloys chosen to investigate the mechanical properties, based on tensile stress, of the as-cast
Mg−xZn−0.3Ca system in tension were the M-46 (Zn = 0.5%), M-48 (Zn = 2.0%), M-50 (Zn =
4.0%), and M-52 (Zn = 6.0%) samples. The as-cast MgZnCa−RE alloy was studied in tension as
well.
4.2.1 Mechanical property assessment in tension. It can be seen in Figure 43a, that
there is a slight increase in the elastic modulus of the Mg−xZn−0.3Ca samples as the Zn content
increased. However, for all samples, including the MgZnCa−RE sample, it was determined that
the moduli, which ranged from 37-47 GPa, showed no significant difference. This range in
modulus values is in agreement with previous studies that determined that in general, the elastic
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modulus of Mg alloys range from 41
41-45 GPa, which is close to that of human femur bone [12].
As a result, it can be concluded that the experimental alloys in this study will be able to minimize
or reduce the stress-shield
shield phenomena
phenomena, in tension, as Mg bone implants,, which exists in current
metallic implants made of SS or Ti alloys.

Figure 43.. Mechanical properties of Mg-based
based alloys produced in the study in tension:
tension a)
modulus (GPa), b) yield strength (MPa), c) ultimate tensile strength (MPa), d) elongation at
failure (%).
In terms of the yield strength, a similar trend is seen in which the yield strength of the
Mg−xZn−0.3Ca
−0.3Ca system increases from 52.8 MPa (M
(M-46) to 92.0 MPa (M-52)
52) as Zn content
increases. This trend in yield strength behavior is also seen in the ultimate tensile strength (UTS)
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and the elongation at failure (EL) values in terms of the increase in UTS and EL values as a
function of the increase of Zn content. This occurrence is in agreement with other studies which
concluded that the tensile mechanical integrity of the Mg−Zn−Ca system increased significantly
by the addition of Zn element [25].
However, it can be observed for the Mg−xZn−0.3Ca samples that when the Zn content
reached 4.0 wt.%, the UTS and EL properties reached its peak values of 199.1 MPa and 9.3%
respectively, which was similarly observed by other studies in terms of reaching a peak value.
When Zn content exceeds more than 4.0 wt.%, in the solidification process, the Zn atom would
be rejected by the α-Mg and enhanced in the residual liquid in which often cause the formation
of eutectic structures and micro-porosity [71]. This may give insight into the reduction of UTS
and EL values of the M-52 sample.
4.2.2 Mechanical property assessment in compression. Figure 44 shows the
compressive test results at room temperature of selected investigated alloys compared with
99.97% pure Mg. The alloys chosen to investigate the mechanical properties of the
Mg−xZn−0.3Ca system in compression were the M-47 (Zn = 1.0%), M-49 (Zn = 3.0%), M-51
(Zn = 5.0%), and M-53 (Zn = 10.0%) samples. The results regarding the compressive
mechanical properties follow a similar trend to the results obtained in tension.
4.2.3 Effects of Zn addition on the mechanical properties. In general, the experimental
alloys have very good mechanical properties. Adding alloy elements to pure Mg changes the
mechanical properties to more robust values. Good mechanical properties are achieved by solid
solution strengthening based on the relatively high solid solubility of Zn in Mg at high
temperatures. Additionally, in the Mg−Zn−Ca system, the presences of the Ca2Mg6Zn3 and
Ca2Mg5Zn13 phases could enhance the strength and toughness of Mg [71, 112, 113]. Figure 28
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describes the presences of the aforementioned Ca2Mg6Zn3 phase, which increased in occurrence
with the addition of Zn, which provided the increase in strength seen in the present study.

Figure 44. Mechanical
cal properties of Mg
Mg-based alloys produced in this study in compression:
compression a)
modulus (GPa), b) yield strength
trength (MPa), c) ultimate tensile strength (MPa).
As discussed in chapter 2, the stacking fault energy of Mg alloys decreased with high
content of solid solution Zn [44].. Consequently, extended dislocations are broadened which can
result in higher difficulty in the iinitiation of non-basal slip. As a result, better mechanical
strengths including high ductility up to 4% Zn is observed which is seen in this study. Therefore,
the present work showed that adding Zn to the Mg
Mg−0.3Ca
−0.3Ca alloy marked an increase of the
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mechanical properties. But Zn content exceeding 4.0 wt.% compromised the microstructure
causing a decline in the mechanical properties of the Mg−xZn−0.3Ca alloy system.
4.2.4 Effects of REEs on the mechanical properties. The MgZnCa−RE sample has the
highest yield strength, ultimate tensile strength, and elongation at failure values, compared to the
Mg−xZn−0.3Ca alloys, at 121.0 MPa, 232.7 MPa, and 11.3% respectively. This is in agreement
with studies that found that RE-containing Mg alloys are stronger than AZ91 alloy [114]. More
specifically, the addition of Gd and Nd in Mg improves the tensile and compression strengths
[50, 111]. The secondary phase disperse inside the grains can effectively block dislocation slip
within grains, combined with proper grain size, can improve the creep resistance and ultimately
the mechanical properties of RE-containing Mg alloys. The secondary phase
(Mg74.8Zn15.2Nd4.3Gd4.2) detected inside the grain boundaries in this study, which was effective in
maintaining the grain size during heat treatment processing, could have an effect on hindering
the slip dislocation in the MgZnCa−RE alloys.
4.3 Immersion Corrosion Assessment
4.3.1 MgZnCa alloys.
4.3.1.1 Corrosion rates of as-cast MgZnCa samples in 0.9% NaCl. The corrosion rates
(mm/year) of the as-cast Mg−xZn−0.3Ca alloys based on a 10 day immersion in 0.9% NaCl
solution is described in Figure 45. A 99.97% pure Mg control alloy was used for all immersion
tests reported in this study. When comparing the experimental alloys to the control, the M-46
(0.5 wt.% Zn) and M-47 (1.0 wt.%) samples had lower corrosion rates at 1.6 and 1.4 mm/year
respectively than the pure Mg at 2.9 mm/year. As the Zn level goes from 2.0 wt.% to 4.0 wt.%
(M-48 thru M-50), the corrosion rate increases to around 4.4 mm/year. However, the one-way
ANOVA determined that the M-46, M-47, M-48, M-49 and M-50 samples did not show any
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statistical differences in the mean corrosion rate values. It is not until the Zn level reaches to 5.0
wt.% (M-51)
51) that there is a significant increase in the mean.

Figure 45.. Average corrosion rate, in mm/year, of the as
as-cast Mg−xZn−0.3Ca
−0.3Ca alloys in 0.9%
NaCl solution after 10 days immersion
immersion.
The corrosion rate for the samples with 5.0
5.0-10 wt.% increase to around 7.1 mm/year.
mm/y
In
terms of comparing the effects of increasing Zn content to the corrosion behavior of the Mg-0.3
Mg
wt.%Ca system, there was an initial reduction in the corrosion rate up to 1 wt.% of Zn, but the
corrosion rate experienced an overall increase as the Zn content increased to 10.0 wt.%.
wt.% These
results are similar to Bakhsheshi--Rad et al. findings in which it was discovered that in the
Mg−0.5Ca−xZn alloy, the addition of Zn content up to 1 wt.% increased the corrosion resistance
whilst further addition of Zn up to 9% reversed the effect [103]. The reason forr the reduction in
corrosion behavior of the Mg−xZn
Zn−0.3Ca alloys as a function of the increased Zn content is the
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formation of coarse secondary phase precipitates shown in Figure 28, which grew thicker and
more profound during the solid solidification processes at higher Zn levels. This precipitation
accelerated the corrosion rate due to the different electrochemical behaviors between the α-Mg
and the precipitates. This difference in electrochemical behavior causes galvanic couples
between the secondary phase and the Mg matrix. For the M-46 and M-47, only the primary Mg
matrix could be detected which results in higher corrosion resistance and a lower corrosion rate
because there are no significant galvanic coupling behaviors between different phases. As the Zn
level continue to increase, the Mg2Ca and the Ca2Mg6Zn3 phases being to precipitate. It is
suggested that the Mg2Ca is more reactive than the Ca2Mg6Zn3 phase and the α-Mg matrix while
the Ca2Mg6Zn3 phase is less active than the α-Mg [103]. As a result, the Mg2Ca would corrode
faster than the other two phases. Further addition of Zn results in the disappearance of the Mg2Ca
phase, therefore the Ca2Mg6Zn3 phase acts as the cathode and α-Mg phase as the anode. The αMg phase cannot further support the Ca2Mg6Zn3 phase as the Zn level increased generating
higher corrosion rates.
The degradation process of Mg alloys is an electrochemical procedure, which describes
the electron flow between the anode and cathode. Normally for Mg in an aqueous environment,
the Mg alloy reacts with the fluids on the surface and gets dissolved in the surrounding
environment. Ultimately, the local pH at the surface of the Mg increases above 10 and then an
oxide layer of Mg hydroxide develops. The overall corrosion reaction is given below [115]:
Mg JeM ; 2HA OJ`gM ; MgJOHMA JeM ' HA JhM

Equation 14

This overall reaction includes the following partial reactions:

Mg JeM ; Mg A=
J`gM ' 2e (anodic reaction)

Equation 15


2 HA OJ`gM ' 2e ; HA JhM ' 2OHJ`gM
(cathodic reaction)

Equation 16
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Mg A=
J`gM ' 2OHJ`gM ; MgJOHMA JeM (product formation)

Equation 17

In physiological environments, more severe corrosion occurs which forms Mg chloride and
hydrogen gases that can be toxic to living cells. The following chemical equations summarize the
corrosion reaction of Mg in an electrolytic physiological environment [12]:
Mg JeM ' 2HA O ; MgJOHMA JeM ' HA JhM

Equation 18

Mg JeM ' 2Cl
J`gM ; MgClA

Equation 19

Due to the formation of the porous Mg(OH)2 layer, which attaches to the matrix, the corrosion of
the specimen slows [103]. However, the presence of Cl in the physiological solution transforms
the Mg(OH)2 layer into a soluble MgCl2. The breakdown of the Mg(OH)2 layer promotes further
dissolution of the specimen. The MgCl2 dissolves into Mg2+ and 2Cl causing an increase in
hydroxide ions near the surface of the specimen which increases the pH value of the solution.
Witte et al. [116] discovered that this corrosion layer promotes osteo-inductivity and
osteo-conductivity and therefore the release of these ions during degradation is believed to be
safe and has good biocompatibility. Bakhsheshi-Rad et al. [103] discovered this protective layer
phenomena in their study, in which the formation of white particles in the form of closely packed
needle-like crystal structures on the sample surface, was present. This was observed during the
10 day immersion test conducted in this study. Even though galvanic corrosion was observed
post immersion test, a white protective film was also observed during the immersion test. The
dissolution of Mg (Equation 15) and the cathodic reaction occurred at the same time due to the
occurrence of galvanic corrosion accompanied by hydrogen evolution (Equation 16). The Cl−
concentration which is present in the 0.9% NaCl solution transformed the layer of Mg(OH)2 into
the soluble form of MgCl2.
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4.3.1.2 Corrosion rates of as
as-cast MgZnCa samples in MEMα. The same corrosion
behavior was observed in the Mg
Mg−xZn−0.3Ca alloys after a 10 day immersion test in Fetal
Bovine Serum (FBS)-containing
containing MEMα cell culture medium shown in Figure 46.
46
The main difference in the results of the MEM
MEMα cell culture solution and the 0.9% NaCl
solution is that the pure Mg had a lower corrosion rate than the M
M-46
46 alloy but the one-way
one
ANOVA determined
mined that this difference was not significant. Additionally, the overall corrosion
rates of the Mg−xZn−0.3Ca alloys were reduced in the MEM
MEMα medium compared to the 0.9%
NaCl results. This finding is in agreement with many publications that indicate that there
t
is a
tendency for corrosion to slow down when proteins are added to the corrosion medium
irrespective of the composition of the medium [117].

Figure 46.. Average corrosion rate in mm/year of as
as-cast Mg−xZn−0.3Ca
0.3Ca alloys in MEMα
MEM cell
culture solution.
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MEMα solution as a function of
Figure 47 shows the variation of pH values of the MEM
immersion duration for the Mg−xxZn−0.3Ca alloys. It can be observed that the pH variation for
the Mg−xZn−0.3Ca alloys and the pure Mg all followed a similar trend which is confirmed by
the one-way
way ANOVA. The pH variation rate decreased as the immersion time increased. In the
first 24 hours, both the pure Mg and Mg
Mg−xZn−0.3Ca
−0.3Ca alloys reacted acutely with the MEMα
MEM
solution.
lution. This is a function of the Mg and H2O reacting in the MEMα solution generating OH−
and causing the pH values of the solutions to increase.

Figure 47.. pH variation of MEM
MEMα cell culture solution versus the immersion testing time for ascast Mg−xZn−0.3Ca alloys.
After 24 hours immersion, all the pH values ooff the samples tend to stabilize around 9.3.
This stabilization is important because the pH value around implants was also reported to a
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crucial factor that can influence osteoblast differentiation and proliferation [118-120]. Previous
studies have shown how the pH affects bone metabolism in that during metabolic acidosis (pH <
7.35) the activity of osteoblasts declines, whereas during metabolic alkalosis (pH > 7.45)
osteoblast activity increases [119-125]. The pH variations of the MEMα solution (Figure 47)
suggest that the experimental alloys can retain an environment that is conducive to healthy bone
activity.
4.3.1.3 Corrosion rates of heat treated MgZnCa samples in 0.9% NaCl. Figure 48
presents the average corrosion rates of the heated treated M-50 samples compared to its as-cast
counterpart and pure 99.97% Mg in the 0.9% NaCl solution for 10 days. The corrosion rate of
the M-50 alloy experienced a significant increase as a function of the heat treatment processing.
The different electrochemical behavior experienced between the α-Mg and the intermetallic
secondary phase still plays a role in the corrosion behavior but that role is altered because of the
heat treatment conditioning. Figure 31 shows that most of the solute elements have been
dissolved into the primary Mg matrix which caused more refinement in the grain boundaries
throughout the heat treated samples.
Additionally, based on the grain size data given in Figure 33, there is a significant
increase in the average grain diameter of the heat treated (300°C 20 h + 480°C xh) M-50 samples
compared with the as-cast sample. It has been shown that grain size can have a noteworthy effect
on the corrosion behavior of an alloy. Fine grain size microstructures of Mg alloys were proven
to provide a more negative corrosion potential which facilitates the formation of a layer of
protective corrosion products that can increase the corrosion resistance [109]. A comprehensive
study on the effects of grain size on corrosion rates of metals was done by Ralston et al. [126]
where it was determined that in the examinations of systems where low rates of corrosion occur
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ems that exhibit some level a passivity, corrosion rates decreased with grain size
or systems
reduction.
Improved resistance generally is attributed to an ability of high grain boundary density
surfaces to passivate more readily [127, 128].. Furthermore, Ralston suggested that the grain
refinement is restricted to controlling the rate of anodic reactions and have little effect on the rate
of cathodic reactions because cathodic reaction
reactionss are based on electronic more than ionic
conduction. This is confirmed by Hoog et al. studies [110] which concluded that for cast Mg, a
decrease in corrosion current (icorr) was a function of the decreased grain size.

Figure 48. Average corrosion rate
rate, in mm/y, of as-cast and heat treated M-50 alloys in 0.9%
NaCl solution.
This phenomenon is confirmed in the present study. In the as-cast
cast condition, the higher
grain boundary density dictated the passivation rate on the surfaces of the as-cast
cast
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Mg−xZn−0.3Ca material because of the continuous system of the secondary phase. This
continuous system acts as a barrier to the aqueous environment and corrodes the Mg matrix first,
but is stopped by the secondary phase barrier. The first two heat treatment parameters created
holes within this barrier as a result of the dissolution of the secondary phase producing a more
non-continuous system. As a result, the refinement of the grain boundary density and subsequent
increase of grain boundary diameter reduced the corrosion resistance of the first two heat treated
alloys. As discussed above, the Ca2Mg6Zn3 phase acts as the cathode and α-Mg phase as the
anode. This resulted in the structure of the α-Mg phase to corrode faster around the Ca2Mg6Zn3
phase which is illustrated in Figure 49. Since the grain size increased compared to the as-cast M50 sample, the α-Mg phase is more prevalent which means more overall corrosion and higher
corrosion rates. The last two heat treatment parameters experienced a reduction in corrosion rates
compared to the first two treatment parameters because the corrosion slows down since the
microstructure is more of a single type phase compared to the first two parameters which makes
it corrode a little more uniformly. This increased the corrosion resistance slightly of the heat
treated alloys.
4.3.2 MgZnCa−RE alloys. The corrosion rates of the as-cast and heat treated
MgZnCa−RE samples are shown in Figure 50. It is determined that there is no significant
difference in the average corrosion rate of the as-cast MgZnCa−RE alloy compared to the
99.97% pure Mg which are 2.41 and 2.89 mm/year respectively. It can be seen that the as-cast
MgZnCa−RE alloy’s corrosion rate is lower than the M-48 alloy. It has been discovered by
Birbilis et al. [51] that REEs tend to ennoble the Ecorr values of Mg alloys because the REEs are
more thermodynamically stable than the Mg and the MgZnCa−RE intermetallics themselves are
resistant to corrosion.
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Figure 49. SEM micrographs of post immersion test surface morphology of M-50 alloys heat
treated at 300°C for 20 h and then 480°C for 2, 4, 6, and 8 h.
Moreover, the presence of Gd has been shown to improve the corrosion behavior of Mg
alloys up to 10 wt.% [50, 129]. However, Birbilis further explains that based on the response of
individual MgZnCa−RE intermetallics; these intermetallics may increase Icorr overall, and
therefore, owing to their electrochemical properties that differ from the matrix, can lead to
galvanic corrosion. This phenomenon is seen in Figure 51a, which describes the corrosion
morphology of the as-cast MgZnCa−RE sample post immersion in 0.9% NaCl solution. It can be
seen that there is corrosion on the surface which appears to be mainly from the Mg matrix. There
is a significant drop in the corrosion rates of the MgZnCa−RE alloys, once the heat treatment
conditioning is introduced, to around 0.45 mm/year. The extension in heat treatment time beyond
2 h does not show any significant variation on the corrosion rate.
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Figure 50. Average corrosion rate
rate, in mm/year, of as-cast and heat treated MgZnCa
gZnCa−RE alloys in
0.9% NaCl solution.
It can be seen in Figure 42
42a,
a, that the heat treatment conditions dissolve the solute
elements into the primary matrix creating a single phase type of microstructure. Therefore, one
aspect of the improved corrosion resistance can be attributed to the reduction of the galvanic
coupling effect between the secondary phase and the primary matrix. This may explain the
corrosion morphology of the MgZnCa
MgZnCa−RE alloys post immersion in 0.9% NaCl solution, seen in
Figure 51,, which shows that there is more uniform corrosion on the surface of the heat treatment
samples. However, the dissolution of secondary precipitates was also observed for the heat
treated Mg−xZn−0.3Ca
−0.3Ca alloys, but the opposite effect occurred in that the corrosion resistance
decreased. Consequently, another factor must be at play in the improved corrosion resistance of
the heat treated alloys.
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Figure 51. SEM micrographs of the surface morphology of MgZnCa−RE samples post
immersion test in 0.9% NaCl solution in the as-cast and heat treated conditions.
Figure 42b illustrates the grain growth restricting qualities of the MgZnCa−RE samples
after T4 heat treatment is applied. This consistency with the grain size after heat treatment is
another factor in the improved corrosion resistance of the MgZnCa−RE after T4 heat treatment.
Ultimately the reduction in the electrochemical coupling between of the secondary and primary
phases, and the grain size restriction of the REEs within the grain boundary during the solution
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treatment process served as a driving force for the increased corrosion resistance and the
decreased corrosion rates of the heat treated MgZnCa−RE alloys.
4.4 Cytocompatibility Assessment
4.4.1 Live/dead assay.
4.4.1.1 Live/dead fluorescent images of MgZnCa alloys. The first study used to assess
the cytocompatibility of the experimental alloys was the in-direct Live/Dead assay. The
fluorescent OM images of the Live/Dead staining of the MC3T3 cells after 24 hours of
incubation under M-50 alloy extracts is illustrated in Figure 52. These OM images show cells
seeded with as-cast and heat treated (300°C 20 h + 480°C 2 h and 8 h) M-50 extracts of MEMα
diluted from 100% to 25%. It can be seen that the majority of cells at each extract composition
and dilution are alive and show healthy cell morphology. According to the ISO 10993-5: 2009
standard [130] the cytotoxic effects of the as-cast M-50 extracts at each dilution were given a
grade of 0-1 (Table 8, Appendix) meaning that in terms of the qualitative images of cell
morphology by the extract, the reactivity of the cells was minor. This is in agreement with Xia et
al. [32] who determined that the as-extruded Mg−4.0Zn−0.2Ca alloy had the same grade. For the
100% 2 h heat treated M-50 extract, it can be seen that there is a reduction of cell growth
compared to the lower in dilution extracts. Consequently, the ISO Grade is a 1-2. This reduction
in cell density can be attributed to the corrosion behavior of the heat treated M-50 alloys seen in
Figure 48. The increased corrosion rate of the 2 h treated samples compared to both the as-cast
and the 8 h treated M-50 samples in the 0.9% NaCl solution suggests that there is a higher level
on Mg ions in corresponding extract. This increase in ions could have reduced the
cytocompatibility of the extract and consequently have a negative effect on the cell density as
seen in Figure 52. The cytocompatibility of the 8 h heat treated M-50 extract at all dilutions was
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given a grade of 0-1 which is similar to Sun et al. [44] who determined there Mg−4.0Zn−0.2Ca
alloy which was homogenized at 330°C for 10 h and 400°C for 5 h had a grade between 0-1.
Again the corrosion behavior of this alloy suggests that the Mg ion levels within the extract are
lower than the 2 h treatment samples and is why it received a better grade.
As-cast

300°C 20h+480°C 2h

300°C 20h+480°C 8h

100%
Extract

1000 µm

1000 µm

1000 µm

1000 µm

1000 µm

1000 µm

1000 µm

1000 µm

1000 µm

50%
Extract

25%
Extract

Figure 52. Fluorescent OM images of Live/Dead staining of MC3T3 osteoblast cells incubated
under as-cast and heat treated M-50 alloy extract gradient of MEMα solution for 24 h.
4.4.1.2 Live/dead fluorescent images of MgZnCa−RE alloys. The fluorescent OM
images of the Live/Dead staining of the MC3T3 cells incubated with MgZnCa−RE extracts are
shown in Figure 53. The MEMα extracts dilutions were composed of as-cast MgZnCa−RE and
heat treated (400°C 20 h + 500°C 2 h and 8 h) MgZnCa−RE alloys. As seen in the M-50 OM
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Live/Dead staining images, the cells in these images all have healthy cell morphology, no
reduction of cell growth, and the majority of cells fluoresce green indicating the life of the cells.
As a result, the qualitative ISO Grade for each MgZnCa−RE extract is given a grade of 0.
As-cast

400°C 20h + 500°C
2h

400°C 20h + 500°C
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Figure 53. Fluorescent OM images of Live/Dead staining of MC3T3 osteoblast cells incubated
under as-cast and heat treated MgZnCa−RE alloy extract gradient of MEMα solution for 24 h.
It can be noted that the intensity of the green fluorescence within the live cells incubated
with the MgZnCa−RE extracts are more vivid than the images of the cells incubated with the M50 extracts. This indicates that the MgZnCa−RE extracts are more cytocompatibile with the
MC3T3 cells than the M-50 extracts. The positive qualitative results of this study is in agreement
with Feyerabend et al. [49] in which he discovered the medium level RE containing elements,

111
which include Nd and Gd, show better cytotoxic effects than light level RE elements when
looking at viability of macrophages, osteoblast-like cells and stem cells exposed to different
REEs.
4.4.1.3 Cell coverage based on live fluorescent images. The corresponding average area
of live cell coverage based on the fluorescent OM Live/Dead images was determined and shown
in Figure 54. For the cells incubated with M-50 extracts (Figure 54a), the two-way ANOVA
determined that extract composition has a significant effect on the results at the p < 0.05 level
[F(2, 24) = 4.83, p = 0.0173]. Additionally, it was determined that the extract dilution was even
more significant effect than the extract composition on the results at the p < 0.05 level [F(3, 24)
= 27.28, p < 0.0001]. For the 100% concentrated as-cast M-50 extract, there was a significant
reduction (P < 0.01) in the live cell coverage compared to the negative control. This reduction
was more than 30% of the negative control mean and therefore it is concluded that the 100% ascast M-50 extract has a cytotoxic effect on the MC3T3 cells according to the ISO standard [130].
As the extract dilution increases, the cell coverage increases, but is still lower than the control.
This indicates that the as-cast M-50 alloy hinders cell proliferation at higher alloy ion
concentrations. The cells that were treated with the 2 h and 8 h M-50 heat treated 100% extracts
showed a significant increase (P < 0.001) in cell coverage between the means values compared
with the negative control. The drop in cell coverage of the heat treated extracts is higher in
magnitude than the as-cast extract. This suggests the heat treated M-50 100% extracts not only
hinder healthy cell proliferation, but decreased the cytocompatibility of the M-50 system as well.
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Figure 54. Average area of livee cell coverage after 24 h of incubation based on the fluorescent
OM Live/Dead images: a) M-50 extracts and b) MgZnCa−RE extracts.
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The diluted heat treated extracts showed no significant difference from the negative
control and the difference did not exceed 30% which indicates positive cytocompatiblity. This
increase in the hindrance of cell proliferation of the heat treated extracts can attributed to the
effects of the treatment processing on the microstructure of the M-50 alloys. Figure 33 describes
how the treatment conditions significantly increased the grain size of the M-50 system which
caused a significant reduction in corrosion resistance (Figure 48). The cytocompatibility of the
extract solutions is based on the corrosion reactivity between the alloy and the corrosion
medium. Consequently, the heat treated extracts consist of a higher concentration of Mg ions.
However, the inherent biocompatible nature of the Mg, Zn, Ca elements resulted in the M-50
extracts not killing off the cells which is seen in the Live/Dead images. Optimizing the heat
treatment processing is vital in creating viable biomaterials purposed for orthopaedic implant
applications.
The live cell coverage illustrated in Figure 54b describe the OM staining images of cells
incubated under MEMα extract composed of MgZnCa−RE alloys. The two-way ANOVA
determined that the extract composition is considered to have a significant effect (p < 0.05 level
[F(2, 24) = 4.10, p = 0.0295]) on the results and the extract dilution is considered to have a very
significant impact (p < 0.05 level [F(3, 24) = 7.28, p = 0.0012]) on the results. It is determined
that the reduction in the average area of live cell coverage of the cells incubated with the 100%
as-cast MgZnCa−RE extract compared to the negative control is 30.5%. This difference barely
meets the 30% constraint suggested by the ISO standard which indicates that the as-cast
MgZnCa−RE extract is considered to have positive cytocompatibility with the cells. The diluted
extracts show no significant difference and no need exceed 30% which is similar to the M-50
results.
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The cells incubated with the 2 h heat treated extract also show a significant reduction in
live cell coverage, but this reduction is not significant enough to suggest that the extract has
negative cytocompatibility with the cells. The cell reduction for the 8 h extract is determined not
to be significant and doesn’t show any negative cytocompatibility. It can be noted that the 8 h
heat treated extract has the best cell coverage compare to the 2 h and as-cast extracts and the ascast has the worst. This trend can also be contributed to the effects of the treatment process on
the microstructure of the MgZnCa−RE system. The grain size restricting nature of REEs in Mg
during the treatment process coupled with the successful dissolution of solute atoms into the
primary matrix caused a significantly increased in the corrosion resistance of the MgZnCa−RE
system (Figure 50). According to the Live/Dead images and the live cell coverage data, the
MgZnCa−RE system has shown to have an overall positive cytocompatibility with the MC3T3E1 cell line.
4.4.1.4 Effects of protein-containing medium on the results. It must be noted that the
cell medium composition and the presence of proteins within the medium can alter the corrosion
characteristics of an alloy which ultimately can affect its cytocompatibility. There are many
studies that show that in vitro and in vivo corrosion experiments differ in their results which stem
from the fact that in vivo takes place in a very complicated environment which can affect its
properties to some extent [117, 131-133]. As explained in section 4.3.1 of this dissertation, the
corrosion medium has an impact on the speed and corrosion product formation. As a result, the
tendency for corrosion to slow down when proteins are added to the corrosion medium
regardless of medium composition [117]. For example, Willumeit et al. [117] incubated 99.94%
pure Mg in DMEM under cell culture conditions for 74 h. It was determined that the osmolality
of the solution, which can be attributed mainly to the Mg content of the solution, increased with
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the increased amount of proteins within the solution. It is commonly believed that an increase of
proteins in a solution would lead to corrosion resistance and consequently to a decrease in
osmolality. However, Willumeit’s findings contradict this paradigm but he does still conclude
that the findings in his study point towards the belief that there is a mechanism of corrosion
protection by proteins. In this study, the Mg alloys were immersed in FBS-containing MEMα
medium which were seeded onto the cells. The protein found in this medium coupled with the
buffering capacities could have helped strengthen the corrosion resistance in the MgZnCa−RE
alloys which attributes to the positive cytocompatibility of the extract with the MC3T3-E1 cells.
4.4.2 MTT assay. The second study used to assess the cytocompatibility of the
experimental alloys with the MC3T3-E1 cells was the MTT assay. The MTT assay assessment is
a commonly used cytotoxicity test because it is a test that is financial accessible and easy to
conduct. As discussed in section 3.5.3, this type of assay is a colorimetric assay that measures the
transformation or reduction of yellow 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT) by mitrochondrial succinate dehydrogenases in viable cells [134]. However, it
must be noted that the use of a MTT test can lead to false positive or negative results in the case
of Mg materials. This is caused by the ability of Mg in alkaline environments to produce
tetrazolium salt, which could lead to a change in colors similar to the formation of formazan in
MTT cells [44]. Consequently, the results could be different than what is actually occurring.
Thus, in this study, the results of the MTT assay was closely compared to the results found in the
Live/Dead study in the previous section.
4.4.2.1 Metabolic activity of the MgZnCa alloys. The total mitochondrial activity is
related to the number of viable cells; therefore, the MTT assay is used to quantitatively evaluate
the cytocompatibility of the experimental alloy extracts on the cells. The evaluation of the MTT
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assay used in this study was based on the average percent of metabolic activity (Equation 12) of
cells after 24 and 72 hours of incubation.
The percent of metabolic activity for cells treated with as-cast and heat treated M-50
MEMα extracts are presented in Figure 55. After 24 hours of incubation, it is determined that the
100% as-cast M-50 extract creates a significant reduction in metabolic activity compared to the
negative control. This reduction is more than 30% which indicates a negative cytocompatible
behavior. The metabolic activity of both the 100% heat treated extracts show a significant
reduction compared to the negative control and also are determined to have a cytotoxic effect on
the cells. This trend is in agreement with the live/dead cell coverage seen in Figure 54a. As
discussed in the previous section, the corrosion behavior of the alloys attributed to the ionic
release of Mg+2 after the 72 hours of static soaking of the M-50 alloys into the extract medium.
Wang et al. [135] asserted that the Mg+2 concentration of the WE magnesium alloy extracts
greatly varied in their cytotoxicity tests indicating that Mg+2 ions played a key role in the
cytocompatibility evaluation in vitro.
In terms of comparing the as-cast and the heat treatment extracts to one another based off
the negative control, it can be seen that there is no significant difference between the three
extracts. These findings are consistent with Sun et al. [44] who concluded that there was no
significant difference between the relative growth rate, which was determined from MTT assay
analysis, of L-929 cells cultured in as-cast and extruded Mg−4.0Zn−0.2Ca extracts after 24
hours. The diluted extracts of all three conditions in this study show no significant difference
with the negative control and therefore are considered to have good cytocompatibility with the
cells outside of the 2 h heat treated extract which is treated as an outlier. This is also in
agreement with the Live/Dead cell area of coverage done in this study.
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Figure 55.. Average percent of metabolic activity of MC3T3 cells cultured under as-cast
as
and heat
treated M-50 extract dilutions for: a) 24 h and b) 72 h.
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When studying the development of a grain structure, the size of the grains in an alloy
varies with the rate of nucleation and growth which can influence certain mechanical and
physical properties [62]. More specifically, smaller grains can alter the corrosion behavior and
consequently the biological performance of an alloy. As stated previously in section 4.1.2, the
one-way ANOVA compared the as-cast and heat treated (300°C 20 h + 480°C 2 h and 8 h) M-50
samples and determined that there was a significant difference in the mean grain size values
among the differently processed alloys. This suggested that the treatment conditions used for this
experiment had an effect on increasing the grain size through coalescence and therefore could be
attributed to the metabolic levels of the corresponding cells showing reduced cytocompatibility
with the M-50 alloy. Further studies must be done to determine if refining the grain size of the
M-50 alloys may alter the cytocompatible behavior enough to acceptable levels.
After 72 hours, the extract compositions at the 100% and 50% dilutions significantly
decreased in metabolic activity. This drop was significant enough to determine that both
dilutions showed cytotoxic effects. This enhancement in negative cytocompatibility seen in the
100% and 50% dilutions may be attributed to the extended incubation time. This extended
incubation time created an over absorption of the highly concentrated Mg+2 ions by the cells in
the extract solutions. At the 25% and 10% dilutions, there were no cytotoxic effects shown for
the three extract compositions. Overall, the metabolic activity of the extracts composed of higher
Mg concentrations was reduced at an extended 72 hour incubation time compared to the first 24
hours. However the diluted extracts still showed no cytotoxic effects. More work must be done
to understand what specific ions are in the extract and at what concentrations these ions exist to
get a better understanding of the cytocompatibility of these alloys.
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Ultimately the M-50 alloy system shows negative cytocompatibility when interacting
with the MC3T3 cells according to both the MTT assay. According to the Live/Dead images this
toxicity mainly affects the cell proliferation capabilities whereas the extracts do not have a major
effect in terms of killing the cells. This affect in the hindrance of cell proliferation can be
reduced or eliminated by diluting the extract which means the alloy system may be able to be
employed in a biological system that has good fluid flow.
4.4.2.2 Metabolic activity of the MgZnCa−RE alloys. The percent of metabolic activity
for cells treated with as-cast and heat treated MgZnCa−RE MEMα extracts are presented in
Figure 56. For the initial 24 hour incubation time (Figure 56a), all three extracts at all dilutions
show no significant difference compared to the negative controls. It must be noted that the 100%
concentrated extracts all have high standard deviations which is due to outlier data points in each
extract group which is indicative of measurement error or experimental error by the user.
Additionally, the difference in means for each extract is less than 30% which denotes that there
is positive cytocompatibility of the MgZnCa−RE alloys with the MC3T3 cells. This is in
agreement with the qualitative and quantitative Live/Dead staining results seen in the previous
section. After 72 hours (Figure 56b), it can be seen that 100% concentrated extracts show a
significant decrease in metabolic activity compared to the negative controls which indicate a
cytotoxic effect. Nonetheless, the diluted extracts still show no significant difference and no
cytotoxic effects. RE containing Mg alloys showing good cell viability is a consistent occurrence
to the point where Mg alloys with 5.2-9.9 wt.% RE and 3.7-5.5 wt.% Y have been claimed in a
patent, and WE43 (4 wt.% Y and 3 wt.% RE) is a commercially available Mg alloy [9, 135].
Additionally, Feyerabend et al. [49] studies showed that the WE43 alloy is favorable to
aluminum-containing alloys in terms of cell viability.
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Figure 56.. Average percent of metabolic activity of MC3T3 cells cultured under as-cast
treated MgZnCa−RE
RE extract dilutions for: a) 24 h and b) 72 h.
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However, the viability reactions exhibited by cells based of REEs vary from element to
element. For example, for Mg alloys with high solid solubility’s of Y, Gd, and Dy, Y was found
to exhibit effects on viability and inflammatory reactions of macrophages, whereas the cellular
reaction to Gd and Dy is comparably low [49].
4.4.2.3 Effects of using a cell line on the results. When performing, evaluating, and
interpreting the in vitro cytotoxicity experiments, it is important to understand that the type of
cell line used and the nature of the in vitro test conducted can play a major role in the analysis.
For example, the human osteosarcoma cell line (MG63), tumor-derived mouse macrophage cell
line (RAW 264.7), and human umbilical cord perivascular cells (HUCPV) were compared to
understand the difference in reaction of cell lines and primary cells [49]. From the analysis of
Mg and Ca, it was determined the RAW 264.7 are the most sensitive cells for the influence of
salts, and HUCPV tends to be the most robust cellular assay system. Furthermore, it was
concluded that primary osteoblasts showed a lower susceptibility to lanthanum (La) compared to
MG63 cells.
The MC3T3-E1 cells used in this study are known as a cell line or sub-cloned cell which
means they were derived from a primary cells. Primary cells are cells that are isolated straight
from the tissue with no passages and therefore are morphologically similar to the parent tissue.
Primary cells are considered by to be more physiologically similar to in vivo cells and represent
the best experimental models for in vivo situations [136]. However primary cells are generally
more difficult to culture than cell lines and ultimately have a limited life span. Cell lines are a
more robust type of culture that can be utilized for long-term studies. They are also easier to
work with than primary cells even though their behavior in vitro may not represent the in vivo
situation. The rationale behind using cell lines in this study is based on the consideration that the
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cytocompatibility assessment in this study is used an initial material screening evaluation for the
experimental alloys. As a result, it was decided that using the more durable cell line culture was
ideal.
4.5 Recommendations for Orthopaedic Applications and Further Discussion
There are four main criteria to consider when selecting implant materials. The first
criterion that must be considered is the selection of a suitable application for the implementation
of the implant material. Inherently, the purpose of this study is to develop biodegradable Mg
implant materials for orthopaedic applications. Orthopaedics is a broad branch of medicine
involving the musculoskeletal system. The purpose of an orthopaedic implant device, more
specifically an implant device designed for the skeletal system, is to provide temporary
mechanical support throughout the bone healing process. For biodegradable implants, the
physical and mechanical integrity of the implant must be strong long enough to allow proper
bone healing and then completely dissolve with an appropriate degradation rate that will not be
harmful to the human body [137].
The second criterion to consider is the biological conditions within the environment that
the implant material will be interacting. It is common knowledge that in vitro testing has its
limitations in terms of the inconsistent correlation with in vivo results [33, 137]. The differences
derive from the differences in the in vitro and in vivo environments in where the in vivo takes
place in a very complex environment which can affect the material reaction to some extent [117,
131-133]. This was the motivation behind conducting immersion corrosion tests, in this study, in
the MEMα cell culture solution for some of the experimental alloys. This was in an effort to test
the experimental alloys in a solution that better represented what is seen in the in vivo in terms of
the aqueous environment. The MEMα cell culture solution is more complex than the 0.9% NaCl
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solution in terms of having an array of different amino acids, vitamins, inorganic salts, and other
components. However, it is still recommended that the experimental alloys in this study should
be examined through some sort of in vivo assessment. In vivo biocompatibility data will facilitate
a better understanding of the possible biological capacities of the current experimental alloys.
The third criterion to be considered is the biological response to the designed materials. Hort et
al. [50] suggests that the impact of released alloying elements must be determined on human
cells or cell lines for in vitro tests. For this study, the MC3T3-E1 cell line was used which is a
cell line derived from mouse calvaria. Therefore it is recommended that further in vitro studies
must be done on the experimental alloys developed in this study utilizing human cells to get a
more acceptable depiction of the cytocompatibility in regards to humans. Furthermore, an MTT
assay was utilized in this study for one of the quantitative cytocompatibility assessments. It has
been shown that the use of Mg materials with a MTT assay is known to give false positives and
false negatives [131, 138]. To combat against these effects, the MTT test in this study was
confirmed by the Live/Dead staining results. As another recommendation, the MTT tests should
be substituted with non-metabolic type assay. For example, the BrdU assay is an assay whose
measurement principle is based on luminescence instead of absorption as seen with the MTT
assays [139]. The BrdU assay detects Bromodeoxy Uridine (5-Bromo-2-DeoxyUridine, BrdU)
nucleosides which are incorporated into cellular DNA during cell proliferation and therefore is a
true measure of cell proliferation. Additionally, it was concluded that corroding Mg does not
influence the results of the BrdU assay which makes it a more reliable assay when conducting
cytocompatibility assessment on Mg alloys [131]. Moreover, in an effort to get a better
representation of the cytocompatibility of the alloy, it is suggested that primary cell lines be used
in future studies on the best materials because primary cell culture is more physiologically
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similar to in vivo cells. Also understanding the relationship between ionic concentration and cell
death is vital to getting better insight on the cytocompatibility behavior. Therefore it is suggested
that inductively coupled plasma mass spectrometry (ICP-MS) be conducted which is an
analytical technique used for elemental determinations and is capable of detecting metals and
non-metals at concentrations as low as one part per million. Through the ICP-MS technique,
specific species present within an extract can be determined.
The last criterion to consider when selecting an implant material is the material
properties. The capability of the material in terms of degradation behavior and mechanical
strength is important when assessing the implementation of said material into a suitable medical
application. Hort et al. [50] explains that the selection of an application and the required
properties provides a target for the design of implant materials and the material design must be
adjusted until the material meet the target requirements.
For this study, the material properties of the experimental alloys were assessed and
compared to the required properties of bone and literature suggestions to provide
recommendations of on where the experiment alloys would garner possible success. Table 9
(Appendix) lists the average values for mechanical and physical properties of wet embalmed
cortical bone from younger and older men [140]. Table 10 and Table 11 (Appendix) lists
approximate estimates of the recovery time for different bone fractures and ligament tears
respectively. For bone fractures, the implant mechanical support should last longer than 12
weeks depending on the clinical conditions. Additionally, Erinc et al. [141] recommended that
the properties for biomaterials designed for bone fixtures needs to be as follows: corrosion rate
less than 0.5 mm/year in simulated body fluid at 37°C; strengths higher than 200 MPa; and
elongation higher than 10%. For the Mg−xZn−0.3Ca alloys, the compressive strengths meet the
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requirement suggested by Erinc. In terms of the ultimate tensile strengths, only the M-50 alloy
met this criterion. However, cytotoxicity assays determined that the M-50 alloy has negative
cytocompatibility with the MC3T3 cells according to ISO standards. The Live/Dead images
indicated that this toxicity mainly affects the cell proliferation capabilities whereas the extracts
do not have a major effect in terms of killing the cells because of the inherent biocompatible
nature of the Mg, Zn, Ca elements. This affect in the hindrance of cell proliferation can be
reduced or eliminated by diluting the extract. As a result, it is recommended that the M-50 alloy
should be explored for use in biological systems that have good fluid flow. However, all of the
Mg−xZn−0.3Ca alloys produced in this study have a corrosion rate higher than 0.5 mm/year.
More work must be done to optimize the Mg−xZn−0.3Ca microstructure to produce more
attractive materials properties.
In terms of the as-cast MgZnCa−RE samples, the tensile strength meets the 200 MPa
requirement suggested by Erinc. However, the as-cast MgZnCa−RE has a corrosion rate of 2.4
mm/ year. This corrosion value is drastically reduced to around 0.46 mm/year after solution
treatment which bolsters the cyto-compatibility of the system. Therefore the MgZnCa−RE alloy
produced in this study has the potential to be successful as a biodegradable orthopaedic implant
material. Further mechanical studies must be done on the heat treated MgZnCa−RE to confirm
that the mechanical integrity is not altered after the introduction of heat treatment processing.
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CHAPTER 5
Conclusion
The purpose of this study was to develop biodegradable Mg alloys for orthopaedic
applications. The Mg−Zn−Ca alloy was the underpinning system for where these materials were
developed from. The Zn content of this system was varied from 0.5 to 10.0 wt.% at a constant Ca
composition of 0.3 wt.%. Optical microscopy images of these samples showed that the level of
Zn content has an influence on the microstructure because the intermetallic phase observed along
the grain boundaries and within the grains become more potent and the eutectics are thickened as
the Zn concentration increases. Both the CaMg2 and Ca2Mg6Zn3 phases were detected in the
alloys with a Zn level of 2.0%. As the Zn level increased to 6%, there was a suppression of the
CaMg2 phase. The Mg12Zn13 phase started to precipitate for the samples with 10% of Zn.
Based off the optical micrographs, it is also determined that there is a refinement in the
average grain diameter by the increase of Zn content up to 4 wt.%. This reduction in grain size
has a significant effect on the mechanical integrity and corrosion behavior of this group of ascast alloys. The strength of the as-cast Mg−xZn−0.3Ca alloy increases with the increased Zn
content up to 4.0 wt.%. When Zn content exceeds more than 4.0 wt.%, the mechanical strengths
decreases as a result of the Zn atom being rejected by the α-Mg and enhanced in the residual
liquid in which often cause the formation of eutectic structures and micro-porosity. Additionally,
the increase in Zn content caused an initial reduction in the corrosion rate up to 1 wt.% of Zn, but
the corrosion rate experienced an overall increase as the Zn concentration increased to 10.0
wt.%.
The introduction of a double stage T4 solution treatment process on the
Mg−3.0Zn−0.3Ca and Mg−4.0Zn−0.3Ca samples determined that solution temperatures ranging
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from 400°C to 480°C with treatment times from 2 h to 144 h was able to activate the solute
atoms enough for diffusion to occur which explains the significant decrease in secondary area
compared to as-cast samples. However, due to the relatively high temperatures used for the heat
treatment processing, most of the secondary phase at the grain boundaries dissolved causing
grain assimilation which reduced the grain boundary density and increased the average grain
diameter compared to the as-cast counterparts. Consequently, the corrosion resistance of the heat
treated Mg−4.0Zn−0.3Ca samples is significantly reduced. This stems from the different
electrochemical behaviors experienced between the α-Mg and the intermetallic secondary phase
in which the Ca2Mg6Zn3 phase acts as the cathode and α-Mg phase as the anode causing the αMg phase to corrode faster around the Ca2Mg6Zn3 phase.
REEs were also introduced into the Mg−2.0Zn−0.3Ca alloy at 2.0 wt.%. It can be seen
that the REEs have a grain refining effect on the Mg−xZn−0.3Ca alloy since average grain
diameter is considerably lower than the samples with no REEs. The secondary phase
(Mg74.8Zn15.2Nd4.3Gd4.2) detected inside the grain boundaries of the MgZnCa−RE alloy, hinders
the slip dislocation causing the MgZnCa−RE sample to have the highest yield strength, ultimate
tensile strength, and elongation at failure values among the Mg−xZn−0.3Ca alloys produced in
this study. It can also be seen that the as-cast MgZnCa−RE alloy’s corrosion rate is lower than
the Mg−2.0Zn−0.3Ca counterpart with no rare earth additions because the REEs tend to ennoble
the Ecorr values of Mg alloys because the REEs are more thermodynamically stable and the
MgZnCa−RE intermetallics themselves are resistant to corrosion.
The introduction of the double stage T4 solution heat treatment process on the as-cast
MgZnCa−RE alloy creates a single phase type of microstructure. Additionally, REEs played an
important role in restricting grain growth during the solution treatment process. As a result there
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was a significant drop in the corrosion rates once the heat treatment conditioning is introduced
because of the grain size restriction effect of REEs and the reduction of the galvanic coupling
effect between the secondary phase and the primary matrix.
For the Mg−xZn−0.3Ca alloys, the compressive strengths meet the requirement suggested
by Erinc for materials designed for bone fixture implants. In terms of the ultimate tensile
strengths, only the M-50 (Zn = 4%) alloy meets this criterion. However, cytotoxicity assays
determined that the as-cast and heat treated M-50 alloys have negative cytocompatibility with the
MC3T3 cells according to ISO standards. The Live/Dead images indicated that this toxicity
mainly affects the cell proliferation capabilities whereas the extracts do not have a major effect
in terms of killing the cells because of the inherent biocompatible nature of the Mg, Zn, Ca
elements. This affect in the hindrance of cell proliferation can be reduced or eliminated by
diluting the extract which means the alloy system may be able to be employed in a biological
system that have good fluid flow. Additionally, all of the Mg−xZn−0.3Ca alloys produced in this
study have a corrosion rate higher than 0.5 mm/year, which exceeds the recommended rate;
therefore more work must be done to optimize the Mg−xZn−0.3Ca microstructure to produce
more attractive materials properties. Nevertheless, the M-50 alloy is a good place to start the
optimization utilizing heat treatment processing.
The MgZnCa−RE alloy may have potential to be successful as a biodegradable
orthopaedic implant material because samples have positive cytocompatibility with the MC3T3
cells according to ISO standards and the tensile strengths meets the 200 MPa requirement
suggested by Erinc. However, the as-cast MgZnCa−RE has a corrosion rate of 2.4 mm/ year
which is a little high for orthopaedic implants. This corrosion value is drastically reduced to
around 0.46 mm/year after T4 solution treatment which meets Erinc requirements. More
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mechanical studies must be done on the heat treated MgZnCa−RE to confirm that the mechanical
integrity is not altered after the introduction of heat treatment processing.
In summary, the study described in this dissertation shows that there is potential for the
Mg−xZn−0.3Ca alloy system to be developed into an orthopaedic implant material. Despite the
challenges of obtaining ideal materials properties for biodegradable Mg alloys purposed for
implantable applications, this alloy system can be constructed to meet implant requirements
through unique heat treatment processing techniques and innovative alloying methods which
include the addition of REEs. The necessity for innovation in medical devices that improve the
quality of life through the creation of new alloys with the capabilities of biodegradation and
bioabsorption without toxicity effects makes this alloy system worth the energy of future
exploration and development and possible commercialization.
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Appendix

Figure 57.. Mechanical properties of the Mg
Mg−Gd alloys in tension: (a) F (as-cast),
cast), (b) T4, and (c)
T6; and in compression: (d) F, (e) T4 and (f) T6 [50].
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(a)

(b)

Figure 58. (a) Melting point diffusivities and (b) normalised activation energies for various
classes of materials [108].
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Table 7
SEM-EDS analysis of actual composition of the Mg−xZn−0.3Ca alloy system after casting.
Alloy Name

designed composition

actual composition

M-46

wt.%
Mg-0.5Zn-0.3Ca

Mg
wt.% at.%
97.76 99.04

Zn

Ca

wt.%
1.76

at.%
0.67

wt.%
0.49

at.%
0.30

M-47

Mg-1.0Zn-0.3Ca

97.47

98.98

2.23

0.84

0.30

0.19

M-48
M-49
M-50

Mg-2.0Zn-0.3Ca
Mg-3.0Zn-0.3Ca
Mg-4.0Zn-0.3Ca

96.01
94.77
94.49

M-51

Mg-5.0Zn-0.3Ca

92.48

98.38
97.89
97.81
96.95

3.57
4.80
5.19
7.03

1.36
1.85
2.00
2.74

0.43
0.43
0.31
0.49

0.26
0.27
0.20
0.32

M-52
M-53

Mg-6.0Zn-0.3Ca
Mg-10.0Zn-0.3Ca

91.98
88.69

96.77
95.41

7.65
11.04

2.99
4.41

0.38
0.28

0.24
0.18

Table 8
Qualitative morphological grading of cytotoxicity of extracts [130].
Grade

Reactivity

0

None

Conditions of all cultures
Discrete intracytoplasmatic granules, no cell lysis, no reduction of
cell growth.

1

Slight

Not more than 20 % of the cells are round, loosely attached and
without intracytoplasmatic granules, or show changes in morphology;
occasional lysed cells are present; only slight growth inhibition
observable.

2

Mild

Not more than 50 % of the cells are round, devoid of
intracytoplasmatic granules, no extensive cell lysis; not more than
50% growth inhibition observable.

3

Moderate

Not more than 70 % of the cell layers contain rounded cells or are
lysed; cell layers not completely destroyed, but more than 50%
growth inhibition observable.

4

Severe

Nearly complete or complete destruction of the cell layers.
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Table 9
Average values for mechanical and physical properties of wet embalmed cortical bone from
younger and older men [140].

Bone

Age

No.
Specimen

Femur

41.5
71.0

35
35

698.23
560.94

100.03
66.69

1.32
1.07

Modulus
of
Elasticity
(MPa)
14.61
13.34

Tibia

41.5
72.0

67
34

813.95
694.31

103.95
82.38

1.76
1.56

18.53
15.89

1.96
1.83

Fibula

33.0
59.0

20
16

636.45
564.86

98.07
78.45

2.10
1.19

18.83
14.91

1.91
1.73

Breaking
Load (N)

UTS
(MPa)

Elongation
(%)

Table 10
Estimated recovery times of common bone fractures [142].
Bone fracture
fingers
metacarpals
distal radius
lower arm
humerus
femoral neck
femoral shaft
tibia
clavicle
scaphoid
pelvis

Recovery time (weeks)
3
4−6
4−6
8−10
6−8
12
12
10
3−12
12+
8−12

Density
(g/cm3)
1.91
1.85
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Table 11
Estimated recovery times of ligament tears [143].
Ligament Rupture
ACL
LCL
MCL
PCL

Recovery time (months)
6−9
3
3
6−9

